{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:18:21Z","timestamp":1791724701456,"version":"4.3.4"},"reference-count":621,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The University of Queensland Research Training Tuition Fee Offset and Research Training Stipend scholarships"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Enterococcus faecalis, Enterococcus faecium and Staphylococcus aureus are both common commensals and major opportunistic human pathogens. In recent decades, these bacteria have acquired broad resistance to several major classes of antibiotics, including commonly employed glycopeptides. Exemplified by resistance to vancomycin, glycopeptide resistance is mediated through intrinsic gene mutations, and\/or transferrable van resistance gene cassette-carrying mobile genetic elements. Here, this review will discuss the epidemiology of vancomycin-resistant Enterococcus and S. aureus in healthcare, community, and agricultural settings, explore vancomycin resistance in the context of van and non-van mediated resistance development and provide insights into alternative therapeutic approaches aimed at treating drug-resistant Enterococcus and S. aureus infections.<\/jats:p>","DOI":"10.3390\/microorganisms11010024","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T02:06:14Z","timestamp":1671674774000},"page":"24","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["Vancomycin Resistance in Enterococcus and Staphylococcus aureus"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7465-2517","authenticated-orcid":false,"given":"Gen","family":"Li","sequence":"first","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Walker","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5085-7163","authenticated-orcid":false,"given":"David M. P.","family":"De Oliveira","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fmicb.2015.01534","article-title":"Enterococcus faecalis from Food, Clinical Specimens, and Oral Sites: Prevalence of Virulence Factors in Association with Biofilm Formation","volume":"6","author":"Anderson","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/CMR.7.4.462","article-title":"Virulence of enterococci","volume":"7","author":"Jett","year":"1994","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1038\/s41598-020-61002-5","article-title":"Surveillance of Enterococcus spp. reveals distinct species and antimicrobial resistance diversity across a One-Health continuum","volume":"10","author":"Zaheer","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1128\/AEM.66.5.2263-2266.2000","article-title":"Quantification of Bacterial Groups within Human Fecal Flora by Oligonucleotide Probe Hybridization","volume":"66","author":"Sghir","year":"2000","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1099\/ijsem.0.004332","article-title":"List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ","volume":"70","author":"Parte","year":"2020","journal-title":"Int. J. Syst. Evol Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gilmore, M.S., Clewell, D.B., Courvalin, P., Dunny, G.M., Murray, B.E., and Rice, L.B. (2002). Enterococci as Members of the Intestinal Microflora of Humans. Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance, ASM Press.","DOI":"10.1128\/9781555817923"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-1605(03)00175-2","article-title":"Taxonomy, ecology and antibiotic resistance of enterococci from food and the gastro-intestinal tract","volume":"88","author":"Klein","year":"2003","journal-title":"Int. J. Food. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3201\/eid0402.980211","article-title":"Multiple-drug resistant Enterococci: The nature of the problem and an agenda for the future","volume":"4","author":"Huycke","year":"1998","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","first-page":"277","article-title":"The Antibiotic Resistance Crisis: Part 1: Causes and Threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4161\/viru.21282","article-title":"Intrinsic and acquired resistance mechanisms in enterococcus","volume":"3","author":"Hollenbeck","year":"2012","journal-title":"Virulence"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Coombs, G.W., Daley, D.A., Yee, N.W.T., Shoby, P., and Mowlaboccus, S. (2022). Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2020. Commun. Dis. Intell., 46.","DOI":"10.33321\/cdi.2022.46.17"},{"key":"ref_12","unstructured":"Gilmore, M.S., Clewell, D.B., Ike, Y., and Shankar, N. (2014). Enterococcal Disease, Epidemiology, and Implications for Treatment. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, Massachusetts Eye and Ear Infirmary."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kouidhi, B., Zmantar, T., Mahdouani, K., Hentati, H., and Bakhrouf, A. (2011). Antibiotic resistance and adhesion properties of oral Enterococci associated to dental caries. BMC Microbiol., 11.","DOI":"10.1186\/1471-2180-11-155"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/08959374930070020701","article-title":"Role of suspected periodontopathogens in microbiological monitoring of periodontitis","volume":"7","year":"1993","journal-title":"Adv. Dent. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1902\/jop.2012.120050","article-title":"Antibiotic Susceptibility of Periodontal Enterococcus faecalis","volume":"84","author":"Rams","year":"2013","journal-title":"J. Periodontol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/1469-0691.12236","article-title":"Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006\u20132009: A population-based cohort study","volume":"20","author":"Pinholt","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1016\/j.jmb.2019.05.030","article-title":"Jekyll and Mr. Hide: How Enterococcus faecalis Subverts the Host Immune Response to Cause Infection","volume":"431","author":"Kao","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14787210.2014.870886","article-title":"Antibiotic resistance in Enterococcus faecium clinical isolates","volume":"12","author":"Cattoir","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1128\/AAC.06299-11","article-title":"Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia","volume":"56","author":"Hayakawa","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/313694","article-title":"Association Between Resistance to Vancomycin and Death in Cases of Enterococcus faecium Bacteremia","volume":"30","author":"Garbutt","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4103\/0255-0857.55437","article-title":"Review of virulence factors of Enterococcus: An emerging nosocomial pathogen","volume":"27","author":"Ravikumar","year":"2009","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/14728222.7.3.311","article-title":"Vancomycin resistance: Occurrence, mechanisms and strategies to combat it","volume":"7","author":"Boneca","year":"2003","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41598-020-57776-3","article-title":"The antibiotic vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucins","volume":"10","author":"Dinu","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/JCM.43.1.462-463.2005","article-title":"Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002)","volume":"43","author":"Treitman","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diagmicrobio.2006.12.022","article-title":"Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY antimicrobial surveillance program","volume":"58","author":"Deshpande","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13756-020-00770-1","article-title":"Enterococcus faecium: From microbiological insights to practical recommendations for infection control and diagnostics","volume":"9","author":"Zhou","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"ofz553","DOI":"10.1093\/ofid\/ofz553","article-title":"Epidemiology of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis Colonization in Nursing Facilities","volume":"7","author":"Davis","year":"2020","journal-title":"Open Forum. Infect. Dis."},{"key":"ref_29","unstructured":"Centers for Disease Control and Prevention (2019). Antibiotic Resistance Threats in the United States, 2019."},{"key":"ref_30","unstructured":"Centers for Disease Control and Prevention (2013). Antibiotic Resistance Threats in the United States, 2013."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e00058-18","DOI":"10.1128\/CMR.00058-18","article-title":"The Enterococcus: A Model of Adaptability to Its Environment","volume":"32","author":"Rice","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/phrev.phrev_21_17","article-title":"Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts\/Compounds with Conventional Antibiotics the Solution?","volume":"11","author":"Cheesman","year":"2017","journal-title":"Pharmacogn. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: A History","volume":"42","author":"Levine","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-94-3-343","article-title":"Vancomycin Therapy in Patients with Impaired Renal-Function: A Nomogram for Dosage","volume":"94","author":"Moellering","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00088-17","DOI":"10.1128\/CMR.00088-17","article-title":"Mobile Genetic Elements Associated with Antimicrobial Resistance","volume":"31","author":"Partridge","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/313949","article-title":"Aminoglycoside Resistance in Enterococci","volume":"31","author":"Chow","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.37.9.1896","article-title":"Characterization of the Chromosomal aac(6\u2019)-Ii Gene-Specific for Enterococcus faecium","volume":"37","author":"Costa","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1021\/bi034148h","article-title":"Kinetic Mechanism of the GCN5-Related Chromosomal Aminoglycoside Acetyltransferase AAC(6\u2032)-Ii from Enterococcus faecium: Evidence of Dimer Subunit Cooperativity","volume":"42","author":"Draker","year":"2003","journal-title":"Biochemistry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0966-842X(97)01033-0","article-title":"Bacterial resistance to aminoglycoside antibiotics","volume":"5","author":"Davies","year":"1997","journal-title":"Trends Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00339581","article-title":"Site-specific recombination promotes linkage between trimethoprim- and sulfonamide resistance genes. Sequence characterization of dhfrV and sulI and a recombination active locus of Tn21","volume":"213","author":"Sundstrom","year":"1988","journal-title":"Mol. Gen. Genet. MGG"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1093\/nar\/13.19.7095","article-title":"Nucleotide sequence of the transposon Tn7 gene encoding an aminoglycoside-modifying enzyme, 3\u201d(9)-O-nucleotidyltransferase","volume":"13","author":"Fling","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0147-619X(85)90052-6","article-title":"Nucleotide sequence analysis of a gene encoding a streptomycin\/spectinomycin adenylyltransferase","volume":"13","author":"Hollingshead","year":"1985","journal-title":"Plasmid"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1093\/nar\/14.21.8625","article-title":"Nucleotide sequence of the AAD(2\u201d) aminoglycoside adenylyltransferase determinant aadB. Evolutionary relationship of this region with those surrounding aadA in R538-1 and dhfrll inR388","volume":"14","author":"Cameron","year":"1986","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside Modifying Enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug. Resist. Updates"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1128\/JB.180.3.714-721.1998","article-title":"Transfer of Tn5385, a composite, multiresistance chromosomal element from Enterococcus faecalis","volume":"180","author":"Rice","year":"1998","journal-title":"J. Bacteriol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s000180200002","article-title":"Association of different mobile elements to generate novel integrative elements","volume":"59","author":"Rice","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijantimicag.2010.11.035","article-title":"In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: Proposition of zone diameter breakpoints","volume":"37","author":"Lascols","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1128\/AAC.42.8.1871","article-title":"Tn916 Family Conjugative Transposons and Dissemination of Antimicrobial Resistance Determinants","volume":"42","author":"Rice","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1128\/AAC.49.7.2954-2958.2005","article-title":"Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis","volume":"49","author":"Ono","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/00365541003699623","article-title":"Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: Efficacy and development of resistance","volume":"42","author":"Chong","year":"2010","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.medmal.2010.12.013","article-title":"In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008","volume":"41","author":"Berenger","year":"2011","journal-title":"Med. Mal. Infect."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/AAC.48.8.3028-3032.2004","article-title":"Impact of Specific pbp5 Mutations on Expression of \u03b2-Lactam Resistance in Enterococcus faecium","volume":"48","author":"Rice","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dkm237","article-title":"Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model","volume":"60","author":"Arias","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1128\/AAC.47.12.3950-3953.2003","article-title":"Structures, Locations, and Transfer Frequencies of Genetic Elements Conferring High-Level Gentamicin Resistance in Enterococcus faecalis Isolates in Greece","volume":"47","author":"Daikos","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijantimicag.2007.10.019","article-title":"A novel structure of Tn4001-truncated element, type V, in clinical enterococcal isolates and multiplex PCR for detecting aminoglycoside resistance genes","volume":"31","author":"Leelaporn","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1261\/rna.2233511","article-title":"Intrinsic resistance to aminoglycosides in Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific methyltransferase EfmM","volume":"17","author":"Galimand","year":"2011","journal-title":"RNA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e02461-16","DOI":"10.1128\/AAC.02461-16","article-title":"Requirement of the CroRS Two-Component System for Resistance to Cell Wall-Targeting Antimicrobials in Enterococcus faecium","volume":"61","author":"Kellogg","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.38.4.693","article-title":"Insertions of IS256-like element flanking the chromosomal \u03b2-lactamase gene of Enterococcus faecalis CX19","volume":"38","author":"Rice","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/AAC.36.10.2265","article-title":"Sequence analysis of the beta-lactamase repressor from Staphylococcus aureus and hybridization studies with two beta-lactamase-producing isolates of Enterococcus faecalis","volume":"36","author":"Smith","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/AAC.36.9.1843","article-title":"Evidence of Incorporation of the Chromosomal Beta-Lactamase Gene of Enterococcus faecalis CH19 into a Transposon Derived from Staphylococci","volume":"36","author":"Rice","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_61","unstructured":"Gilmore, M.S., Clewell, D.B., Ike, Y., and Shankar, N. (2014). Extrachromosomal and Mobile Elements in Enterococci: Transmission, Maintenance, and Epidemiology. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, Massachusetts Eye and Ear Infirmary."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/AAC.32.4.547","article-title":"Plasmids and Pheromone Response of the \u03b2-Lactamase Producer Streptococcus (Enterococcus) faecalis HH22","volume":"32","author":"Murray","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1128\/JB.186.5.1221-1228.2004","article-title":"Role of Class A Penicillin-Binding Proteins in PBP5-Mediated \u03b2-Lactam Resistance in Enterococcus faecalis","volume":"186","author":"Arbeloa","year":"2004","journal-title":"J. Bacteriol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1128\/JB.180.17.4426-4434.1998","article-title":"Genetic Linkage and Cotransfer of a Novel, vanB-Containing Transposon (Tn5382) and a Low-Affinity Penicillin-Binding Protein 5 Gene in a Clinical Vancomycin-Resistant Enterococcus faecium Isolate","volume":"180","author":"Carias","year":"1998","journal-title":"J. Bacteriol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1128\/AAC.49.12.5007-5012.2005","article-title":"Enterococcus faecium low-affinity pbp5 is a transferable determinant","volume":"49","author":"Rice","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e00318-11","DOI":"10.1128\/mBio.00318-11","article-title":"Comparative genomics of enterococci: Variation in Enterococcus faecalis, clade structure in E. faecium, and defining characteristics of E. gallinarum and E. casseliflavus","volume":"3","author":"Palmer","year":"2012","journal-title":"mBio"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1128\/AAC.00488-16","article-title":"Homologous Recombination within Large Chromosomal Regions Facilitates Acquisition of \u03b2-Lactam and Vancomycin Resistance in Enterococcus faecium","volume":"60","author":"Lebreton","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fmicb.2016.01581","article-title":"Co-diversification of Enterococcus faecium Core Genomes and PBP5: Evidences of pbp5 Horizontal Transfer","volume":"7","author":"Novais","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/AAC.42.3.534","article-title":"The gene encoding the low-affinity penicillin-binding protein 3r in Enterococcus hirae S185R is borne on a plasmid carrying other antibiotic resistance determinants","volume":"42","author":"Raze","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e00199-11","DOI":"10.1128\/mBio.00199-11","article-title":"Reciprocal Regulation of Cephalosporin Resistance in Enterococcus faecalis","volume":"2","author":"Kristich","year":"2011","journal-title":"mBio"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/plas.2001.1544","article-title":"Sequence of the 50-kb conjugative multiresistance plasmid pRE25 from Enterococcus faecalis RE25","volume":"46","author":"Schwarz","year":"2001","journal-title":"Plasmid"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1365-2958.2003.03387.x","article-title":"Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium","volume":"47","author":"Grady","year":"2003","journal-title":"Mol. Microbiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1128\/AAC.37.12.2593","article-title":"Study of heterogeneity of chloramphenicol acetyltransferase (CAT) genes in streptococci and enterococci by polymerase chain reaction: Characterization of a new CAT determinant","volume":"37","author":"Bentorcha","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0147-619X(92)90060-N","article-title":"Nucleotide sequence of the chloramphenicol resistance determinant of the streptococcal plasmid pIP501","volume":"28","author":"Horaud","year":"1992","journal-title":"Plasmid"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1128\/AAC.00509-12","article-title":"Correlation between Mutations in liaFSR of Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints","volume":"56","author":"Munita","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"26925","DOI":"10.1073\/pnas.1916037116","article-title":"Antimicrobial sensing coupled with cell membrane remodeling mediates antibiotic resistance and virulence in Enterococcus faecalis","volume":"116","author":"Khan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1128\/AAC.00207-11","article-title":"Genetic Basis for Daptomycin Resistance in Enterococci","volume":"55","author":"Palmer","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMoa1011138","article-title":"Genetic Basis for In Vivo Daptomycin Resistance in Enterococci","volume":"365","author":"Arias","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1194\/jlr.R700018-JLR200","article-title":"Thematic Review Series: Glycerolipids. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes","volume":"49","author":"Schlame","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ernst, C.M., Staubitz, P., Mishra, N.N., Yang, S.J., Hornig, G., Kalbacher, H., Bayer, A.S., Kraus, D., and Peschel, A. (2009). The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000660"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Bao, Y., Sakinc, T., Laverde, D., Wobser, D., Benachour, A., Theilacker, C., Hartke, A., and Huebner, J. (2012). Role of mprF1 and mprF2 in the Pathogenicity of Enterococcus faecalis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038458"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686","article-title":"Vancomycin-Resistant Enterococci","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-1119(96)00110-2","article-title":"Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281","volume":"172","author":"Quintiliani","year":"1996","journal-title":"Gene"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1128\/AAC.39.11.2446","article-title":"Identification of Chromosomal Mobile Element Conferring High-Level Vancomycin Resistance in Enterococcus faecium","volume":"39","author":"Handwerger","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0378-1119(96)00022-4","article-title":"Mobilization of vancomycin resistance by transposon-mediated fusion of a VanA plasmid with an Enterococcus faecium sex pheromone-response plasmid","volume":"171","author":"Heaton","year":"1996","journal-title":"Gene"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1574-6968.1994.tb06913.x","article-title":"Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome","volume":"119","author":"Quintiliani","year":"1994","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/jb.175.1.117-127.1993","article-title":"Characterization of Tn1546, a Tn3-Related Transposon Conferring Glycopeptide Resistance by Synthesis of Depsipeptide Peptidoglycan Precursors in Enterococcus faecium BM4147","volume":"175","author":"Arthur","year":"1993","journal-title":"J. Bacteriol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/mdr.1999.5.113","article-title":"Role of Transposon Tn5482 in the Epidemiology of Vancomycin-Resistant Enterococcus faecium in the Pediatric Oncology Unit of a New York City Hospital","volume":"5","author":"Brown","year":"1999","journal-title":"Microb. Drug Resist."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Hung, W.C., Takano, T., Higuchi, W., Iwao, Y., Khokhlova, O., Teng, L.J., and Yamamoto, T. (2012). Comparative Genomics of Community-Acquired ST59 Methicillin-Resistant Staphylococcus aureus in Taiwan: Novel Mobile Resistance Structures with IS1216V. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046987"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","article-title":"Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium","volume":"319","author":"Leclercq","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.00754-08","article-title":"Isolation of VanB-Type Enterococcus faecalis Strains from Nosocomial Infections: First Report of the Isolation and Identification of the Pheromone-Responsive Plasmids pMG2200, Encoding VanB-Type Vancomycin Resistance and a Bac41-Type Bacteriocin, and pMG2201, Encoding Erythromycin Resistance and Cytolysin (Hly\/Bac)","volume":"53","author":"Zheng","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/jac\/dkt092","article-title":"Presence and dissemination of the multiresistance gene cfr in Gram-positive and Gram-negative bacteria","volume":"68","author":"Shen","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/AAC.06091-11","article-title":"First report of the multidrug resistance gene cfr in Enterococcus faecalis of animal origin","volume":"56","author":"Liu","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.3389\/fmicb.2018.02576","article-title":"Complete Genome Sequence and Characterization of Linezolid-Resistant Enterococcus faecalis Clinical Isolate KUB3006 Carrying a cfr(B)-Transposon on Its Chromosome and optrA-Plasmid","volume":"9","author":"Kuroda","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/pro.3589","article-title":"Ribosome protection by ABC-F proteins\u2014Molecular mechanism and potential drug design","volume":"28","author":"Ero","year":"2019","journal-title":"Protein Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/jac\/dkw016","article-title":"Genetic environment of the transferable oxazolidinone\/phenicol resistance gene optrA in Enterococcus faecalis isolates of human and animal origin","volume":"71","author":"He","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e00809-19","DOI":"10.1128\/AAC.00809-19","article-title":"Tn6674 Is a Novel Enterococcal optrA-Carrying Multiresistance Transposon of the Tn554 Family","volume":"63","author":"Li","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fpubh.2020.00518","article-title":"Coexistence of the Oxazolidinone Resistance\u2013Associated Genes cfr and optrA in Enterococcus faecalis From a Healthy Piglet in Brazil","volume":"8","author":"Almeida","year":"2020","journal-title":"Front. Public Health"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1093\/jac\/dkv116","article-title":"A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin","volume":"70","author":"Wang","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1128\/AAC.47.11.3620-3622.2003","article-title":"Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci","volume":"47","author":"Sinclair","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.39.3.577","article-title":"Erythromycin Resistance by Ribosome Modification","volume":"39","author":"Weisblum","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1574-6968.1999.tb13368.x","article-title":"Presence of erm gene classes in Gram-positive bacteria of animal and human origin in Denmark","volume":"170","author":"Jensen","year":"1999","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Cho, S.H., Barrett, J.B., Frye, J.G., and Jackson, C.R. (2020). Antimicrobial Resistance Gene Detection and Plasmid Typing Among Multidrug Resistant Enterococci Isolated from Freshwater Environment. Microorganisms, 8.","DOI":"10.3390\/microorganisms8091338"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Yao, W.M., Xu, G.J., Li, D.Y., Bai, B., Wang, H.Y., Cheng, H., Zheng, J.X., Sun, X., Lin, Z.W., and Deng, Q.W. (2019). Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-3779-8"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/AAC.41.9.1854","article-title":"Enterococcal transposon Tn5384: Evolution of a composite transposon through cointegration of enterococcal and staphylococcal plasmids","volume":"41","author":"Bonafede","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Laverde Gomez, J.A., Hendrickx, A.P.A., Willems, R.J., Top, J., Sava, I., Huebner, J., Witte, W., and Werner, G. (2011). Intra- and Interspecies Genomic Transfer of the Enterococcus faecalis Pathogenicity Island. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016720"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/mdr.2015.0222","article-title":"Enterococcus faecium ST17 from Coastal Marine Sediment Carrying Transferable Multidrug Resistance Plasmids","volume":"22","author":"Morroni","year":"2016","journal-title":"Microb. Drug Resist."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/mdr.2004.10.341","article-title":"Distribution of the erm(B) Gene, Tetracycline Resistance Genes, and Tn1545-like Transposons in Macrolide- and Lincosamide-Resistant Enterococci from Pigs and Humans","volume":"10","author":"Martel","year":"2004","journal-title":"Microb. Drug Resist."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"667415","DOI":"10.3389\/fmicb.2021.667415","article-title":"A Conjugative MDR pMG1-Like Plasmid Carrying the lsa(E) Gene of Enterococcus faecium With Potential Transmission to Staphylococcus aureus","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jac\/dki171","article-title":"Efflux-mediated antimicrobial resistance","volume":"56","author":"Poole","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/jac\/dkt502","article-title":"Presence and genetic environment of pleuromutilin\u2013lincosamide\u2013streptogramin A resistance gene lsa(E) in enterococci of human and swine origin","volume":"69","author":"Li","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1128\/IAI.00165-10","article-title":"Role of Methionine Sulfoxide Reductases A and B of Enterococcus faecalis in Oxidative Stress and Virulence","volume":"78","author":"Zhao","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/AAC.44.4.967-971.2000","article-title":"Macrolide Resistance Genes in Enterococcus spp.","volume":"44","author":"Portillo","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3389\/fmicb.2017.01541","article-title":"Identification of Novel Conjugative Plasmids with Multiple Copies of fosB that Confer High-Level Fosfomycin Resistance to Vancomycin-Resistant Enterococci","volume":"8","author":"Sun","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijantimicag.2013.11.003","article-title":"Fosfomycin resistance among vancomycin-resistant enterococci owing to transfer of a plasmid harbouring the fosB gene","volume":"43","author":"Qu","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Xu, X.G., Chen, C.H., Lin, D.F., Guo, Q.L., Hu, F.P., Zhu, D.M., Li, G.H., and Wang, M.G. (2013). The Fosfomycin Resistance Gene fosB3 Is Located on a Transferable, Extrachromosomal Circular Intermediate in Clinical Enterococcus faecium Isolates. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0078106"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/bi4015852","article-title":"Structure and Function of the Genomically Encoded Fosfomycin Resistance Enzyme, FosB, from Staphylococcus aureus","volume":"53","author":"Thompson","year":"2014","journal-title":"Biochemistry"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1128\/AAC.45.12.3574-3579.2001","article-title":"Characterization of emeA, a norA Homolog and Multidrug Resistance Efflux Pump, in Enterococcus faecalis","volume":"45","author":"Jonas","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"648454","DOI":"10.3389\/fmicb.2021.648454","article-title":"Genomic Analysis of Enterococcus spp. Isolated From a Wastewater Treatment Plant and Its Associated Waters in Umgungundlovu District, South Africa","volume":"12","author":"Mbanga","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.2002.tb11041.x","article-title":"Physical and genetic map of Enterococcus faecium ATCC19434 and demonstration of intra- and interspecific genomic diversity in enterococci","volume":"207","author":"Oana","year":"2002","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-1097(03)00929-7","article-title":"Analysis of gyrA and parC mutations in enterococci from environmental samples with reduced susceptibility to ciprofloxacin","volume":"231","author":"Petersen","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.42.2.433","article-title":"Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis","volume":"42","author":"Kanematsu","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/AAC.00274-07","article-title":"Role of a qnr-Like Gene in the Intrinsic Resistance of Enterococcus faecalis to Fluoroquinolones","volume":"51","author":"Leclercq","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/AAC.46.12.3823-3828.2002","article-title":"Identification of vat(E) in Enterococcus faecalis Isolates from Retail Poultry and Its Transferability to Enterococcus faecium","volume":"46","author":"Simjee","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.44.2.433-436.2000","article-title":"Mechanisms of Resistance to Quinupristin-Dalfopristin among Isolates of Enterococcus faecium from Animals, Raw Meat, and Hospital Patients in Western Europe","volume":"44","author":"Soltani","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/AAC.39.9.2027","article-title":"Diversity among the Gram-Positive Acetyltransferases Inactivating Streptogramin a and Structurally Related-Compounds and Characterization of a New Staphylococcal Determinant, vatB","volume":"39","author":"Allignet","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/AAC.42.7.1794","article-title":"Characterization of a Staphylococcal Plasmid Related to pUB110 and Carrying Two Novel Genes, vatC and vgbB, Encoding Resistance to Streptogramins A and B and Similar Antibiotics","volume":"42","author":"Allignet","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-1119(93)90350-C","article-title":"Sequence of a staphylococcal gene, vat, encoding an acetyltransferase inactivating the A-type compounds of virginiamycin-like antibiotics","volume":"130","author":"Allignet","year":"1993","journal-title":"Gene"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1128\/AAC.43.12.2823","article-title":"Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants","volume":"43","author":"Roberts","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/AAC.00798-09","article-title":"Characterization of two newly identified genes, vgaD and vatH, conferring resistance to streptogramin A in Enterococcus faecium","volume":"54","author":"Jung","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ncomms2470","article-title":"Mechanism of tetracycline resistance by ribosomal protection protein Tet(O)","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"21501","DOI":"10.1007\/s11356-016-7369-7","article-title":"Antibiotic resistance, efflux pump genes and virulence determinants in Enterococcus spp. from surface water systems","volume":"23","author":"Molale","year":"2016","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/jac\/dkl069","article-title":"Identification of Tn5397-like and Tn916-like transposons and diversity of the tetracycline resistance gene tet(M) in enterococci from humans, pigs and poultry","volume":"57","author":"Agerso","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/AEM.07763-11","article-title":"Detection of a Common and Persistent tet(L)-Carrying Plasmid in Chicken-Waste-Impacted Farm Soil","volume":"78","author":"You","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1128\/AEM.70.3.1555-1562.2004","article-title":"Prevalence and Molecular Characterization of Tetracycline Resistance in Enterococcus Isolates from Food","volume":"70","author":"Huys","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41467-022-29274-9","article-title":"Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics","volume":"13","author":"Murina","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/49.3.489","article-title":"Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital","volume":"49","author":"Lim","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_138","first-page":"3039","article-title":"The aacA-aphD gentamicin and kanamycin resistance determinant of Tn4001 from Staphylococcus aureus: Expression and nucleotide sequence analysis","volume":"133","author":"Rouch","year":"1987","journal-title":"J. Gen. Microbiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00382099","article-title":"Tn4001\u2014A Gentamicin and Kanamycin Resistance Transposon in Staphylococcus aureus","volume":"193","author":"Lyon","year":"1984","journal-title":"Mol. Gen. Genet."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0378-1119(83)90022-7","article-title":"Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3\u20195\u201d-aminoglycoside phosphotransferase type III","volume":"23","author":"Courvalin","year":"1983","journal-title":"Gene"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/jb.167.2.631-638.1986","article-title":"Nucleotide sequence analysis of the gene specifying the bifunctional 6\u2019-aminoglycoside acetyltransferase 2\u201d-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities","volume":"167","author":"Ferretti","year":"1986","journal-title":"J. Bacteriol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00383309","article-title":"Nucleotide sequence of a spectinomycin adenyltransferase AAD(9) determinant from Staphylococcus aureus and its relationship to AAD(3\u201d) (9)","volume":"200","author":"Murphy","year":"1985","journal-title":"Mol. Gen. Genet."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1128\/AAC.19.5.766","article-title":"Aminocyclitol-Modifying Enzymes Specified by Chromosomal Genes in Staphylococcus aureus","volume":"19","author":"Kayser","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1128\/AAC.00528-11","article-title":"New Transposon Tn6133 in Methicillin-Resistant Staphylococcus aureus ST398 Contains vga(E), a Novel Streptogramin A, Pleuromutilin, and Lincosamide Resistance Gene","volume":"55","author":"Schwendener","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1128\/AAC.01062-13","article-title":"Emergence of Staphylococcus aureus Carrying Multiple Drug Resistance Genes on a Plasmid Encoding Exfoliative Toxin B","volume":"57","author":"Hisatsune","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jac\/43.2.253","article-title":"The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals","volume":"43","author":"Schmitz","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/plas.1996.0020","article-title":"Characterization of a Staphylococcus aureus transposon, Tn5405, located within Tn5404 and carrying the aminoglycoside resistance genes, aphA-3 and aadE","volume":"35","author":"Derbise","year":"1996","journal-title":"Plasmid"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/AAC.00171-13","article-title":"Novel erm(T)-carrying multiresistance plasmids from porcine and human isolates of methicillin-resistant Staphylococcus aureus ST398 that also harbor cadmium and copper resistance determinants","volume":"57","author":"Kadlec","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/AAC.37.5.1144","article-title":"blaI and blaR1 Regulate \u03b2-Lactamase and PBP 2a Production in Methicillin-Resistant Staphylococcus aureus","volume":"37","author":"Hackbarth","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Pence, M.A., Haste, N.M., Meharena, H.S., Olson, J., Gallo, R.L., Nizet, V., and Kristian, S.A. (2015). Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and Virulence. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136605"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1128\/AAC.37.9.1966","article-title":"Genes Involved in the Regulation of \u03b2-Lactamase Productionin Enterococci and Staphylococci","volume":"37","author":"Zscheck","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/mr.51.1.88-134.1987","article-title":"Antimicrobial Resistance of Staphylococcus aureus: Genetic Basis","volume":"51","author":"Lyon","year":"1987","journal-title":"Microbiol. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/BF03547026","article-title":"Occurrence of the blaZ gene in penicillin resistant Staphylococcus aureus isolated from bovine mastitis in Denmark","volume":"40","author":"Larsen","year":"1999","journal-title":"Acta Vet. Scand."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/AAC.46.9.2797-2803.2002","article-title":"Frequency of Disinfectant Resistance Genes and Genetic Linkage with \u03b2-Lactamase Transposon Tn552 among Clinical Staphylococci","volume":"46","author":"Sidhu","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00267851","article-title":"Physical Mapping of Staphylococcus aureus Penicillinase Plasmid pI524: Characterization of an Invertible Region","volume":"175","author":"Murphy","year":"1979","journal-title":"Mol. Gen. Genet."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/10766290152773374","article-title":"Genetic Linkage Between Resistance to Quaternary Ammonium Compounds and \u03b2-Lactam Antibiotics in Food-Related Staphylococcus spp.","volume":"7","author":"Sidhu","year":"2001","journal-title":"Microb. Drug Resist."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1099\/00221287-59-3-289","article-title":"The Genetics of Penicillinase Production in Staphylococcus aureus Strain PS80","volume":"59","author":"Asheshov","year":"1969","journal-title":"J. Gen. Microbiol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1365-2958.1990.tb00669.x","article-title":"Tn552, a novel transposable element from Staphylococcus aureus","volume":"4","author":"Rowland","year":"1990","journal-title":"Mol. Microbiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1128\/jb.169.7.3082-3087.1987","article-title":"Translational Fusion with a Secretory Enzyme as an Indicator","volume":"169","author":"Wang","year":"1987","journal-title":"J. Bacteriol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3389\/fmicb.2018.02723","article-title":"Factors Contributing to the Evolution of mecA-Mediated \u03b2-lactam Resistance in Staphylococci: Update and New Insights From Whole Genome Sequencing (WGS)","volume":"9","author":"Miragaia","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1590\/1678-5150-pvb-5680","article-title":"Ceftaroline resistance in Staphylococcus pseudintermedius gene mecA carriers","volume":"38","author":"Scherer","year":"2018","journal-title":"Pesqui. Vet. Bras."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1128\/AAC.03622-14","article-title":"PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates","volume":"58","author":"Long","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1348-0421.1995.tb02239.x","article-title":"Molecular evolution of MRSA","volume":"39","author":"Hiramatsu","year":"1995","journal-title":"Microbiol. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/156652409787581637","article-title":"The Molecular Evolution of Hospital- and Community-Associated Methicillin-Resistant Staphylococcus aureus","volume":"9","author":"Deurenberg","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Rasmussen, G., Monecke, S., Brus, O., Ehricht, R., and Soderquist, B. (2014). Long Term Molecular Epidemiology of Methicillin-Susceptible Staphylococcus aureus Bacteremia Isolates in Sweden. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114276"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/j.1460-2075.1985.tb03929.x","article-title":"Regulation of the inducible chloramphenicol acetyltransferase gene of the Staphylococcus aureus plasmid pUB112","volume":"4","author":"Bruckner","year":"1985","journal-title":"EMBO J."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0378-1119(84)90043-X","article-title":"Expression of a chloramphenicol-resistance determinant carried on hybrid plasmids in gram-positive and gram-negative bacteria","volume":"32","author":"Zyprian","year":"1984","journal-title":"Gene"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1128\/jb.150.2.815-825.1982","article-title":"Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance","volume":"150","author":"Horinouchi","year":"1982","journal-title":"J. Bacteriol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-5793(85)80200-3","article-title":"Chloramphenicol acetyltransferase gene of staphylococcal plasmid pC221. Nucleotide sequence analysis and expression studies","volume":"179","author":"Shaw","year":"1985","journal-title":"Febs Lett."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Clewell, D.B. (1993). Conjugation and Broad Host Range Plasmids in Streptococci and Staphylococci. Bacterial Conjugation, Springer.","DOI":"10.1007\/978-1-4757-9357-4"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1128\/JB.00288-11","article-title":"Characterization of Staphylococcus aureus Cardiolipin Synthases 1 and 2 and Their Contribution to Accumulation of Cardiolipin in Stationary Phase and within Phagocytes","volume":"193","author":"Koprivnjak","year":"2011","journal-title":"J. Bacteriol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"11584","DOI":"10.1074\/jbc.M114.554444","article-title":"Cardiolipin prevents membrane translocation and permeabilization by daptomycin","volume":"289","author":"Zhang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.1812066116","article-title":"Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation","volume":"116","author":"Jiang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"16107","DOI":"10.1038\/s41598-020-73108-x","article-title":"Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"10","author":"Thitiananpakorn","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3389\/fmicb.2018.01086","article-title":"Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/AAC.01682-08","article-title":"Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus","volume":"53","author":"Mishra","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1038\/s41598-021-84481-6","article-title":"Genetic and phenotypic diversity of methicillin-resistant Staphylococcus aureus among Japanese inpatients in the early 1980s","volume":"11","author":"Zuo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/AAC.00437-10","article-title":"An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus","volume":"54","author":"Cui","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/infdis\/jis772","article-title":"The RpoB H481Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus","volume":"207","author":"Gao","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Howden, B.P., McEvoy, C.R.E., Allen, D.L., Chua, K., Gao, W., Harrison, P.F., Bell, J., Coombs, G., Bennett-Wood, V., and Porter, J.L. (2011). Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002359"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Poupel, O., Moyat, M., Groizeleau, J., Antunes, L.C.S., Gribaldo, S., Msadek, T., and Dubrac, S. (2016). Transcriptional Analysis and Subcellular Protein Localization Reveal Specific Features of the Essential WalKR System in Staphylococcus aureus. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151449"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1128\/JB.00645-07","article-title":"New insights into the WalK\/WalR (YycG\/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus","volume":"189","author":"Dubrac","year":"2007","journal-title":"J. Bacteriol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/IAI.00195-12","article-title":"The WalKR System Controls Major Staphylococcal Virulence Genes and Is Involved in Triggering the Host Inflammatory Response","volume":"80","author":"Delaune","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/AAC.00432-10","article-title":"VraSR Two-Component Regulatory System Contributes to mprF-Mediated Decreased Susceptibility to Daptomycin in In Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/AAC.00356-06","article-title":"Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus","volume":"50","author":"Gardete","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/AAC.50.1.336-343.2006","article-title":"VraSR Two-Component Regulatory System and Its Role in Induction of pbp2 and vraSR Expression by Cell Wall Antimicrobials in Staphylococcus aureus","volume":"50","author":"Yin","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(00)04403-2","article-title":"Whole genome sequencing of meticillin-resistant Staphylococcus aureus","volume":"357","author":"Kuroda","year":"2001","journal-title":"Lancet"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2958.2003.03599.x","article-title":"Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus","volume":"49","author":"Kuroda","year":"2003","journal-title":"Mol. Microbiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/491711","article-title":"Vancomycin Resistance in Gram-Positive Cocci","volume":"42","author":"Courvalin","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1090956","article-title":"Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus","volume":"302","author":"Weigel","year":"2003","journal-title":"Science"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/AAC.00908-07","article-title":"Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan","volume":"52","author":"Zhu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/AAC.00346-09","article-title":"VanA-type vancomycin-resistant Staphylococcus aureus","volume":"53","author":"Courvalin","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00018-010-0389-4","article-title":"Mobile genetic elements of Staphylococcus aureus","volume":"67","author":"Malachowa","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/AAC.00871-08","article-title":"Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureus","volume":"53","author":"Lannergard","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2958.2005.04971.x","article-title":"Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus","volume":"59","author":"Chopra","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/dkf153","article-title":"Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101","volume":"50","author":"Price","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1128\/AAC.01542-06","article-title":"Genetic basis of resistance to fusidic acid in staphylococci","volume":"51","author":"McLaws","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1128\/AAC.01689-12","article-title":"Emergence of Sequence Type 779 Methicillin-Resistant Staphylococcus aureus Harboring a Novel Pseudo Staphylococcal Cassette Chromosome mec (SCCmec)-SCC-SCCCRISPR Composite Element in Irish Hospitals","volume":"57","author":"Kinnevey","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Ender, M., Berger-B\u00e4chi, B., and McCallum, N. (2007). Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland. BMC Microbiol., 7.","DOI":"10.1186\/1471-2180-7-62"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1073\/pnas.0402521101","article-title":"Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance","volume":"101","author":"Holden","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/AAC.01772-13","article-title":"A Novel Staphylococcal Cassette Chromosomal Element, SCCfusC, Carrying fusC and speG in Fusidic Acid-Resistant Methicillin-Resistant Staphylococcus aureus","volume":"58","author":"Lin","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1128\/AAC.00131-06","article-title":"The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics","volume":"50","author":"Long","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/650574","article-title":"Resistance to Linezolid Is Mediated by the cfr Gene in the First Report of an Outbreak of Linezolid-Resistant Staphylococcus aureus","volume":"50","author":"Morales","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-2958.2005.04754.x","article-title":"A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: Methylation of 23S ribosomal RNA at A2503","volume":"57","author":"Kehrenberg","year":"2005","journal-title":"Mol. Microbiol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1128\/AAC.01098-07","article-title":"Linezolid Resistance in Staphylococcus aureus: Gene Dosage Effect, Stability, Fitness Costs, and Cross-Resistances","volume":"52","author":"Besier","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1365-2958.2007.05744.x","article-title":"Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid","volume":"64","author":"Toh","year":"2007","journal-title":"Mol. Microbiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1128\/AAC.00071-13","article-title":"Dissemination of a pSCFS3-Like cfr-Carrying Plasmid in Staphylococcus aureus and Staphylococcus epidermidis Clinical Isolates Recovered from Hospitals in Ohio","volume":"57","author":"Mendes","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1128\/AAC.01113-10","article-title":"Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate","volume":"54","author":"Shore","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1128\/AAC.02949-15","article-title":"First Report of cfr-Carrying Plasmids in the Pandemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Staphylococcal Cassette Chromosome mec Type IV Clone","volume":"60","author":"Shore","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/AAC.05420-11","article-title":"Genetic Environment and Stability of cfr in Methicillin-Resistant Staphylococcus aureus CM05","volume":"56","author":"Locke","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1093\/jac\/dkaa323","article-title":"Identification of a novel optrA-harbouring transposon, Tn6823, in Staphylococcus aureus","volume":"75","author":"Zhu","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1128\/AAC.00871-09","article-title":"Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)","volume":"53","author":"Locke","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: The example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1469-0691.2006.01486.x","article-title":"Prevalence of erm genes encoding macrolide-lincosamide-streptogramin (MLS) resistance among clinical isolates of Staphylococcus aureus in a Turkish university hospital","volume":"12","author":"Saribas","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/AAC.35.7.1267","article-title":"Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification","volume":"35","author":"Leclercq","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1128\/AAC.45.5.1603-1604.2001","article-title":"Structural alterations in the translational attenuator of constitutively expressed erm(A) genes in Staphylococcus aureus","volume":"45","author":"Schmitz","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1128\/AAC.45.5.1323-1336.2001","article-title":"Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus","volume":"45","author":"Ito","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jac\/dkt015","article-title":"Detection and new genetic environment of the pleuromutilin-lincosamide-streptogramin A resistance gene lsa(E) in methicillin-resistant Staphylococcus aureus of swine origin","volume":"68","author":"Li","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1128\/AAC.01178-15","article-title":"Characterization of a Novel lsa(E)- and lnu(B)-Carrying Structure Located in the Chromosome of a Staphylococcus aureus Sequence Type 398 Strain","volume":"60","author":"Sarrou","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"e01947-21","DOI":"10.1128\/aac.01947-21","article-title":"Tn560, a Novel Tn554 Family Transposon from Porcine Methicillin-Resistant Staphylococcus aureus ST398, Carries a Multiresistance Gene Cluster Comprising a Novel spc Gene Variant and the Genes lsa(E) and lnu(B)","volume":"66","author":"Ji","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/AAC.48.3.909-917.2004","article-title":"Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus","volume":"48","author":"Huang","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1574-6968.1998.tb13232.x","article-title":"A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus","volume":"167","author":"Matsuoka","year":"1998","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/jac\/dkg188","article-title":"A chromosomal location of the mupA gene in Staphylococcus aureus expressing high-level mupirocin resistance","volume":"51","author":"Udo","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1128\/AAC.05325-11","article-title":"MupB, a New High-Level Mupirocin Resistance Mechanism in Staphylococcus aureus","volume":"56","author":"Seah","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1099\/00222615-47-9-829","article-title":"Heterogeneous location of the mupA high-level mupirocin resistance gene in Staphylococcus aureus","volume":"47","author":"Woodford","year":"1998","journal-title":"J. Med. Microbiol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/mdr.1998.4.185","article-title":"Conjugative transfer of high-level mupirocin resistance and the mobilization of non-conjugative plasmids in Staphylococcus aureus","volume":"4","author":"Udo","year":"1998","journal-title":"Microb. Drug Resist."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1574-6968.1991.tb04346.x","article-title":"Cloning of the gene conferring resistance to mupirocin in Staphylococcus aureus","volume":"61","author":"Dyke","year":"1991","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"795173","DOI":"10.3389\/fmicb.2021.795173","article-title":"Genomic Analysis of Global Staphylococcus argenteus Strains Reveals Distinct Lineages With Differing Virulence and Antibiotic Resistance Gene Content","volume":"12","author":"Goswami","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.1989.tb03566.x","article-title":"Plasmid-mediated resistance to fosfomycin in Staphylococcus epidermidis","volume":"52","author":"Etienne","year":"1989","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"e00537-12","DOI":"10.1128\/mBio.00537-12","article-title":"A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes","volume":"4","author":"Fey","year":"2013","journal-title":"mBio"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Fu, Z., Liu, Y., Chen, C., Guo, Y., Ma, Y., Yang, Y., Hu, F., Xu, X., and Wang, M. (2016). Characterization of Fosfomycin Resistance Gene, fosB, in Methicillin-Resistant Staphylococcus aureus Isolates. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154829"},{"key":"ref_232","first-page":"267","article-title":"Nucleotide sequence of the fosB gene conferring fosfomycin resistance in Staphylococcus epidermidis","volume":"56","author":"Zilhao","year":"1990","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrmicro2393","article-title":"The phage-related chromosomal islands of Gram-positive bacteria","volume":"8","author":"Novick","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000330858","article-title":"Topoisomerase Mutations That Are Associated with High-Level Resistance to Earlier Fluoroquinolones in Staphylococcus aureus Have Less Effect on the Antibacterial Activity of Besifloxacin","volume":"57","author":"Sanfilippo","year":"2011","journal-title":"Chemotherapy"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.37.1.128","article-title":"Fluoroquinolone Resistance Protein NorA of Staphylococcus aureus Is a Multidrug Efflux Transporter","volume":"37","author":"Neyfakh","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/jammr\/2019\/v30i1030245","article-title":"Prevalence of qnr Genes among Multidrug Resistance Staphylococcus aureus from Clinical Isolates","volume":"30","author":"Abdu","year":"2019","journal-title":"J. Adv. Med. Med. Res."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/AAC.46.8.2337-2343.2002","article-title":"Tn5406, a new staphylococcal transposon conferring resistance to streptogramin A and related compounds including dalfopristin","volume":"46","author":"Haroche","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jac\/dkt482","article-title":"Identification of a novel vga(E) gene variant that confers resistance to pleuromutilins, lincosamides and streptogramin A antibiotics in staphylococci of porcine origin","volume":"69","author":"Li","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijantimicag.2012.06.009","article-title":"Identification of novel vga(A)-carrying plasmids and a Tn5406-like transposon in meticillin-resistant Staphylococcus aureus and Staphylococcus epidermidis of human and animal origin","volume":"40","author":"Lozano","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1128\/AAC.44.9.2271-2275.2000","article-title":"Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compounds","volume":"44","author":"Haroche","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.1208037109","article-title":"Structural basis for TetM-mediated tetracycline resistance","volume":"109","author":"Donhofer","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Lima, M.C., de Barros, M., Scatamburlo, T.M., Polyeiro, R.C., de Castro, L.K., Guimaraes, S.H.S., da Costa, S.L., da Costa, M.M., and Moreira, M.A.S. (2020). Profiles of Staphyloccocus aureus isolated from goat persistent mastitis before and after treatment with enrofloxacin. BMC Microbiol., 20.","DOI":"10.1186\/s12866-020-01793-9"},{"key":"ref_243","first-page":"76","article-title":"Distribution of genes encoding tetracycline resistance and aminoglycoside modifying enzymes in Staphylococcus aureus strains isolated from a burn center","volume":"26","author":"Emaneini","year":"2013","journal-title":"Ann. Burns Fire Disasters"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/plas.1993.1045","article-title":"The tet(K) Gene of Plasmid pT181 of Staphylococcus aureus Encodes an Efflux Protein That Contains 14 Transmembrane Helices","volume":"30","author":"Guay","year":"1993","journal-title":"Plasmid"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/fmb.09.30","article-title":"Genetics of antimicrobial resistance in Staphylococcus aureus","volume":"4","author":"Jensen","year":"2009","journal-title":"Future Microbiol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3389\/fmicb.2019.00392","article-title":"Tetracycline Gene Transfer in Staphylococcus xylosus in situ During Sausage Fermentation","volume":"10","author":"Leroy","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1128\/AAC.43.1.141","article-title":"Characterization of Dihydrofolate Reductase Genes from Trimethoprim-Susceptible and Trimethoprim-Resistant Strains of Enterococcus faecalis","volume":"43","author":"Coque","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2958.1989.tb01805.x","article-title":"Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257","volume":"3","author":"Rouch","year":"1989","journal-title":"Mol. Microbiol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.chembiol.2016.11.007","article-title":"MRSA Isolates from United States Hospitals Carry dfrG and dfrK Resistance Genes and Succumb to Propargyl-Linked Antifolates","volume":"23","author":"Reeve","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/jmbi.1996.0770","article-title":"A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance","volume":"266","author":"Dale","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1128\/jb.177.11.2965-2970.1995","article-title":"Characterization of the Gene for the Chromosomal Dihydrofolate Reductase (DHFR) of Staphylococcus epidermidis ATCC 14990: The Origin of the Trimethoprim-Resistant S1 DHFR from Staphylococcus aureus?","volume":"177","author":"Dale","year":"1995","journal-title":"J. Bacteriol."},{"key":"ref_252","first-page":"25","article-title":"Mechanisms of plasmid-mediated resistance to quinolones","volume":"23","year":"2005","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"e00473","DOI":"10.1016\/j.heliyon.2017.e00473","article-title":"Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: A systematic review","volume":"3","author":"Ulrich","year":"2017","journal-title":"Heliyon"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3201\/1106.041204","article-title":"Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex","volume":"11","author":"Willems","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13756-018-0335-z","article-title":"Vancomycin-resistant Enterococcus faecium sequence type 796\u2014Rapid international dissemination of a new epidemic clone","volume":"7","author":"Mahony","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1800351","DOI":"10.2807\/1560-7917.ES.2018.23.29.1800351","article-title":"Outbreak of vancomycin-resistant Enterococcus faecium clone ST796, Switzerland, December 2017 to April 2018","volume":"23","author":"Wassilew","year":"2018","journal-title":"Eurosurveillance"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1128\/JCM.00195-06","article-title":"Molecular Epidemiology of Hospital-Acquired Vancomycin-Resistant Enterococci","volume":"44","author":"Vogel","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1097\/j.pbj.0000000000000125","article-title":"A systematic review and meta-analysis on the prevalence of vancomycin-resistant enterococci (VRE) among Nigerians","volume":"6","author":"Orababa","year":"2021","journal-title":"Porto Biomed. J."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Melese, A., Genet, C., and Andualem, T. (2020). Prevalence of Vancomycin resistant enterococci (VRE) in Ethiopia: A systematic review and meta-analysis. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-4833-2"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/jcpt.13383","article-title":"Prevalence of vancomycin-resistant enterococci in Asia\u2014A systematic review and meta-analysis","volume":"46","author":"Shrestha","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2147\/IDR.S206084","article-title":"Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium: A systematic review and meta-analysis","volume":"12","author":"Shiadeh","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_262","first-page":"788","article-title":"Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?","volume":"7","author":"Prieto","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13756-019-0594-3","article-title":"The rise in vancomycin-resistant Enterococcus faecium in Germany: Data from the German Antimicrobial Resistance Surveillance (ARS)","volume":"8","author":"Markwart","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Pan, S.C., Wang, J.T., Chen, Y.C., Chang, Y.Y., Chen, M.L., and Chang, S.C. (2012). Incidence of and Risk Factors for Infection or Colonization of Vancomycin-Resistant Enterococci in Patients in the Intensive Care Unit. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047297"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4314\/ajid.v5i2.66513","article-title":"Prevalence of hospital-acquired enterococci infections in two primary-care hospitals in osogbo, southwestern Nigeria","volume":"5","author":"Olawale","year":"2011","journal-title":"Afr. J. Infect. Dis."},{"key":"ref_266","first-page":"1131","article-title":"Correlation between Nosocomial Carriage of Vancomycin-Resistant Enterococci and Antimicrobial Use in Taiwan","volume":"104","author":"Lee","year":"2021","journal-title":"Am. J. Trop. Med."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Coombs, G.W., Daley, D.A., Lee, Y.T., and Pang, S. (2019). Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2017. Commun. Dis. Intell., 43.","DOI":"10.33321\/cdi.2019.43.42"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"ref_269","unstructured":"European Centre for Disease Prevention and Control (2022, November 24). Data from the ECDC Surveillance Atlas\u2014Antimicrobial Resistance. Available online: https:\/\/www.ecdc.europa.eu\/en\/antimicrobial-resistance\/surveillance-and-disease-data\/data-ecdc."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"20542","DOI":"10.1038\/s41598-020-77696-6","article-title":"Prevalence of vancomycin-resistant enterococcus in Africa in one health approach: A systematic review and meta-analysis","volume":"10","author":"Alemayehu","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_271","unstructured":"Australian Group on Antimicrobial Resistance (2022, November 24). Sepsis Outcome Programs 2020 Report, Available online: https:\/\/www.safetyandquality.gov.au\/sites\/default\/files\/2022-05\/agar_sepsis_outcome_programs_2020_report_0.pdf."},{"key":"ref_272","unstructured":"Antimicrobial Use and Resistance in Australia Surveillance System (AURA) (2021). AURA 2021: Fourth Australian Report on Antimicrobial Use and Resistance in Human Health, Antimicrobial Use and Resistance in Australia Surveillance System (AURA)."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1128\/JCM.02526-09","article-title":"Molecular epidemiology of vancomycin-resistant Enterococcus faecium: A prospective, multicenter study in South American hospitals","volume":"48","author":"Panesso","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_274","unstructured":"World Health Organisation (2017). Global Priority List of Antibiotic Resistant Bacteria."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10354-020-00796-5","article-title":"Organization of antibiotic stewardship in Europe: The way to go","volume":"171","author":"Kern","year":"2021","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.4081\/idr.2017.6800","article-title":"Antimicrobial Stewardship Initiatives Throughout Europe: Proven Value for Money","volume":"9","author":"Tanke","year":"2017","journal-title":"Infect. Dis. Rep."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"dlaa100","DOI":"10.1093\/jacamr\/dlaa100","article-title":"Antimicrobial stewardship in Australian hospitals: How does compliance with antimicrobial stewardship standards compare across key hospital classifications?","volume":"2","author":"Jones","year":"2020","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-019-0471-0","article-title":"Value of hospital antimicrobial stewardship programs [ASPs]: A systematic review","volume":"8","author":"Nathwani","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13756-021-00931-w","article-title":"Surveillance of antimicrobial resistance in low- and middle-income countries: A scattered picture","volume":"10","author":"Iskandar","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13756-019-0654-8","article-title":"Antimicrobial Resistance in the Asia Pacific region: A meeting report","volume":"8","author":"Yam","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"e00048-19","DOI":"10.1128\/CMR.00048-19","article-title":"Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries","volume":"33","author":"Gandra","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_282","first-page":"e68","article-title":"Antimicrobial stewardship in hospitals in Latin America and the Caribbean: A scoping review","volume":"44","year":"2020","journal-title":"Rev. Panam. Salud Publica"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1017\/ash.2022.47","article-title":"Antimicrobial stewardship in Latin America: Past, present, and future","volume":"2","author":"Fabre","year":"2022","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13756-021-00929-4","article-title":"Barriers to implementing antimicrobial stewardship programs in three low- and middle-income country tertiary care settings: Findings from a multi-site qualitative study","volume":"10","author":"Rolfe","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1473-3099(22)00312-7","article-title":"Antimicrobial resistance data, frugal sequencing, and low-income countries in Africa","volume":"22","author":"Aruhomukama","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/fpd.2020.2892","article-title":"Global Prevalence of Vancomycin-Resistant Enterococci in Food of Animal Origin: A Meta-Analysis","volume":"18","author":"Lawpidet","year":"2021","journal-title":"Foodborne Pathog. Dis."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"j3544","DOI":"10.1136\/bmj.j3544","article-title":"Antimicrobial policy interventions in food animal production in South East Asia","volume":"358","author":"Goutard","year":"2017","journal-title":"BMJ"},{"key":"ref_288","doi-asserted-by":"crossref","unstructured":"Manyi-Loh, C., Mamphweli, S., Meyer, E., and Okoh, A. (2018). Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications. Molecules, 23.","DOI":"10.3390\/molecules23040795"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1073\/pnas.1503141112","article-title":"Global trends in antimicrobial use in food animals","volume":"112","author":"Brower","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"Tiseo, K., Huber, L., Gilbert, M., Robinson, T.P., and Van Boeckel, T.P. (2020). Global Trends in Antimicrobial Use in Food Animals from 2017 to 2030. Antibiotics, 9.","DOI":"10.3390\/antibiotics9120918"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40572-022-00351-x","article-title":"A Review of the Effectiveness of Current US Policies on Antimicrobial Use in Meat and Poultry Production","volume":"9","author":"Wallinga","year":"2022","journal-title":"Curr. Environ. Health Rep."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13756-020-00847-x","article-title":"Antimicrobial use in food animals and human health: Time to implement \u2018One Health\u2019 approach","volume":"9","author":"Pokharel","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13620-019-0154-4","article-title":"European perspectives on efforts to reduce antimicrobial usage in food animal production","volume":"73","author":"More","year":"2020","journal-title":"Ir. Vet. J."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/JB.183.24.7260-7272.2001","article-title":"Analysis of Transcription of the Staphylococcus aureus Aerobic Class Ib and Anaerobic Class III Ribonucleotide Reductase Genes in Response to Oxygen","volume":"183","author":"Masalha","year":"2001","journal-title":"J. Bacteriol."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tim.2019.01.008","article-title":"Commensal Staphylococci Influence Staphylococcus aureus Skin Colonization and Disease","volume":"27","author":"Parlet","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.meegid.2013.04.030","article-title":"Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus","volume":"21","author":"Uhlemann","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/03079450050118386","article-title":"Bacterial chondronecrosis with osteomyelitis (\u2018femoral head necrosis\u2019) of broiler chickens: A review","volume":"29","author":"McNamee","year":"2000","journal-title":"Avian. Pathol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.meegid.2013.08.011","article-title":"Staphylococcus aureus in veterinary medicine","volume":"21","author":"Peton","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3389\/fmicb.2018.02419","article-title":"Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections","volume":"9","author":"Sakr","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-8244(03)00370-5","article-title":"Bridges from hospitals to the laboratory: Genetic portraits of methicillin-resistant Staphylococcus aureus clones","volume":"40","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"601905","DOI":"10.4061\/2011\/601905","article-title":"Characterization of Virulence Factors of Staphylococcus aureus: Novel Function of Known Virulence Factors That Are Implicated in Activation of Airway Epithelial Proinflammatory Response","volume":"2011","author":"Bien","year":"2011","journal-title":"J. Pathog."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1128\/AEM.05316-11","article-title":"Expression of virulence factors by Staphylococcus aureus grown in serum","volume":"77","author":"Oogai","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s11908-010-0119-y","article-title":"Staphylococcal Toxic Shock Syndrome: Mechanisms and Management","volume":"12","author":"Silversides","year":"2010","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_304","first-page":"269","article-title":"Vancomycin Resistance in Staphylococcus aureus","volume":"90","author":"McGuinness","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"17916","DOI":"10.1038\/s41598-018-36206-5","article-title":"Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus isolates at a Chinese tertiary hospital, 2012\u20132017","volume":"8","author":"Peng","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_306","doi-asserted-by":"crossref","unstructured":"Xie, X., Bao, Y., Ouyang, N., Dai, X., Pan, K., Chen, B., Deng, Y., Wu, X., Xu, F., and Li, H. (2016). Molecular epidemiology and characteristic of virulence gene of community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus isolates in Sun Yat-sen Memorial hospital, Guangzhou, Southern China. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1684-y"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1590\/0074-0276140016","article-title":"The multifaceted resources and microevolution of the successful human and animal pathogen methicillin-resistant Staphylococcus aureus","volume":"109","author":"Figueiredo","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/21505594.2017.1335847","article-title":"What is behind the epidemiological difference between community-acquired and health-care associated methicillin-resistant Staphylococcus aureus?","volume":"8","author":"Figueiredo","year":"2017","journal-title":"Virulence"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of Community- and Health Care\u2013Associated Methicillin-Resistant Staphylococcus aureus Infection","volume":"290","author":"Naimi","year":"2003","journal-title":"JAMA"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijmm.2013.02.007","article-title":"Community-associated MRSA: What makes them special?","volume":"303","author":"Otto","year":"2013","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1017\/S0950268820000849","article-title":"Marked increase in community-associated methicillin-resistant Staphylococcus aureus infections, Western Australia, 2004-2018","volume":"148","author":"Bloomfield","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5694\/mja17.00089","article-title":"The increasing importance of community-acquired methicillin-resistant Staphylococcus aureus infections","volume":"207","author":"Agostino","year":"2017","journal-title":"Med. J. Aust."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"668900","DOI":"10.3389\/fmicb.2021.668900","article-title":"Increasing Incidences and Clonal Diversity of Methicillin-Resistant Staphylococcus aureus in the Nordic Countries\u2014Results From the Nordic MRSA Surveillance","volume":"12","author":"Petersen","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s10096-020-03824-9","article-title":"Changing epidemiology of methicillin-resistant Staphylococcus aureus in a low endemicity area\u2014New challenges for MRSA control","volume":"39","author":"Junnila","year":"2020","journal-title":"Eur. J. Clin. Microbiol."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13756-019-0485-7","article-title":"Incidence of community onset MRSA in Australia: Least reported where it is Most prevalent","volume":"8","author":"Cameron","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1017\/S0950268817001716","article-title":"The rise of methicillin resistant Staphylococcus aureus: Now the dominant cause of skin and soft tissue infection in Central Australia","volume":"145","author":"Macmorran","year":"2017","journal-title":"Epidemiol. Infect."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"e00080-15","DOI":"10.1128\/mBio.00080-15","article-title":"Convergent Adaptation in the Dominant Global Hospital Clone ST239 of Methicillin-Resistant Staphylococcus aureus","volume":"6","author":"Baines","year":"2015","journal-title":"mBio"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/22221751.2022.2032373","article-title":"Methicillin-resistant Staphylococcus aureus in China: A multicentre longitudinal study and whole-genome sequencing","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13073-021-00992-x","article-title":"Drivers of methicillin-resistant Staphylococcus aureus (MRSA) lineage replacement in China","volume":"13","author":"Chen","year":"2021","journal-title":"Genome Med."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmi.2016.11.002","article-title":"Methicillin-resistant Staphylococcus aureus among animals: Current overview","volume":"23","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3121\/cmr.2010.944","article-title":"Evidence of multiple virulence subtypes in nosocomial and community-associated MRSA genotypes in companion animals from the upper midwestern and northeastern United States","volume":"9","author":"Lin","year":"2011","journal-title":"Clin. Med. Res."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1172\/JCI38226","article-title":"Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era","volume":"119","author":"DeLeo","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"iv55","DOI":"10.1093\/jac\/dkz288","article-title":"Characterization of MRSA in Canada from 2007 to 2016","volume":"74","author":"Nichol","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1093\/ofid\/ofy210.1054","article-title":"1221. Genetic Characteristics of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Belonging to Clonal Complex 5 (CC5) in Latin-America","volume":"5","author":"Reyes","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"e00816-17","DOI":"10.1128\/AAC.00816-17","article-title":"A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries","volume":"61","author":"Arias","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_326","first-page":"2018","article-title":"Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020","volume":"46","author":"Coombs","year":"2022","journal-title":"Commun. Dis. Intell."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fmicb.2015.00348","article-title":"Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: A systematic review","volume":"6","author":"Abdulgader","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_328","first-page":"7","article-title":"Molecular epidemiology of the community-associated methicillin-resistant Staphylococcus aureus clones: A synthetic review","volume":"91","author":"Junie","year":"2018","journal-title":"Clujul Med."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1111\/j.1444-0903.2005.00985.x","article-title":"Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA)","volume":"35","author":"Gosbell","year":"2005","journal-title":"Intern. Med. J."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/JCM.37.9.2858-2862.1999","article-title":"Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak","volume":"37","author":"Pearman","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_331","doi-asserted-by":"crossref","unstructured":"Preeja, P.P., Kumar, S.H., and Shetty, V. (2021). Prevalence and Characterization of Methicillin-Resistant Staphylococcus aureus from Community- and Hospital-Associated Infections: A Tertiary Care Center Study. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020197"},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1099\/jmm.0.028381-0","article-title":"Detection and characterization of an ST97-SCCmec-V community-associated meticillin-resistant Staphylococcus aureus clone in a neonatal intensive care unit and special care baby unit","volume":"60","author":"Udo","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhin.2012.04.018","article-title":"Community-associated Panton-Valentine leukocidin-negative meticillin-resistant Staphylococcus aureus clone (ST72-MRSA-IV) causing healthcare-associated pneumonia and surgical site infection in Korea","volume":"81","author":"Joo","year":"2012","journal-title":"J. Hosp. Infect."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1086\/593953","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea","volume":"30","author":"Park","year":"2009","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1128\/JCM.01890-09","article-title":"Emergence of SCCmec type IV and SCCmec type V methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leukocidin genes in a large academic teaching hospital in central Switzerland: External invaders or persisting circulators?","volume":"48","author":"Valsesia","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jclinpath-2011-200436","article-title":"Change in meticillin-resistant Staphylococcus aureus clones at a tertiary care hospital in the United Arab Emirates over a 5-year period","volume":"65","author":"Sonnevend","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1017\/S0950268809002234","article-title":"Report of a hospital neonatal unit outbreak of community-associated methicillin-resistant Staphylococcus aureus","volume":"137","author":"Gould","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3201\/eid1302.060781","article-title":"Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections","volume":"13","author":"Maree","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"ref_339","first-page":"40","article-title":"Dissemination of community-associated methicillin-resistant Staphylococcus aureus in a tertiary care hospital","volume":"101","author":"Patel","year":"2008","journal-title":"Antibiotics"},{"key":"ref_340","doi-asserted-by":"crossref","unstructured":"David, M.Z., Cadilla, A., Boyle-Vavra, S., and Daum, R.S. (2014). Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004\u20132005 to 2008. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092760"},{"key":"ref_341","doi-asserted-by":"crossref","unstructured":"Baldan, R., Testa, F., Lor\u00e8, N.I., Bragonzi, A., Cichero, P., Ossi, C., Biancardi, A., Nizzero, P., Moro, M., and Cirillo, D.M. (2012). Factors contributing to epidemic MRSA clones replacement in a hospital setting. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043153"},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1093\/infdis\/jiw444","article-title":"Life After USA300: The Rise and Fall of a Superbug","volume":"215","author":"Planet","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of Resistance: Staphylococcus aureus in the Antibiotic Era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"860436","DOI":"10.3389\/fmicb.2022.860436","article-title":"A 6-Year Update on the Diversity of Methicillin-Resistant Staphylococcus aureus Clones in Africa: A Systematic Review","volume":"13","author":"Lawal","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/ecp.09.26","article-title":"Novel antibiotics for the treatment of Staphylococcus aureus","volume":"2","author":"Ohlsen","year":"2009","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.10.3.505","article-title":"Nasal Carriage of Staphylococcus aureus: Epidemiology, Underlying Mechanisms, and Associated Risks","volume":"10","author":"Kluytmans","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(06)68853-3","article-title":"Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat","volume":"368","author":"Grundmann","year":"2006","journal-title":"Lancet"},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections\u2014United States","volume":"68","author":"Kourtis","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited\u201460 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front. Public Health"},{"key":"ref_351","first-page":"809","article-title":"Some laboratory and clinical experiences with a new antibiotic, vancomycin","volume":"48","author":"Geraci","year":"1956","journal-title":"Proc. Staff Meet. Mayo Clin."},{"key":"ref_352","first-page":"172","article-title":"Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report","volume":"33","author":"Geraci","year":"1958","journal-title":"Proc. Staff Meet. Mayo Clin."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The Nephrotoxicity of Vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/j.amjmed.2009.05.031","article-title":"Vancomycin-associated nephrotoxicity: Grave concern or death by character assassination?","volume":"123","author":"Hazlewood","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features","volume":"21","author":"Cong","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"dlaa114","DOI":"10.1093\/jacamr\/dlaa114","article-title":"Treatment of methicillin-resistant Staphylococcus aureus (MRSA): Updated guidelines from the UK","volume":"3","author":"Brown","year":"2021","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3947\/ic.2016.48.4.267","article-title":"Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia","volume":"48","author":"Choo","year":"2016","journal-title":"Infect. Chemother."},{"key":"ref_358","doi-asserted-by":"crossref","unstructured":"Ducheyne, P. (2011). 4.421\u2014Self-Assembled Prodrugs. Comprehensive Biomaterials, Elsevier.","DOI":"10.1016\/B978-0-08-055294-1.00275-0"},{"key":"ref_359","unstructured":"Patel, S., Preuss, C.V., and Bernice, F. (2022). Vancomycin, StatPearls."},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"46500","DOI":"10.1038\/srep46500","article-title":"Peptidoglycan O-acetylation increases in response to vancomycin treatment in vancomycin-resistant Enterococcus faecalis","volume":"7","author":"Chang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1073\/pnas.1402259111","article-title":"Structural basis for the evolution of vancomycin resistance D,D-peptidases","volume":"111","author":"Stogios","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1128\/JB.188.5.1875-1881.2006","article-title":"Characterization of the bifunctional glycosyltransferase\/acyltransferase penicillin-binding protein 4 of Listeria monocytogenes","volume":"188","author":"Markiewicz","year":"2006","journal-title":"J. Bacteriol."},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3389\/fmicb.2016.01601","article-title":"Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus","volume":"7","author":"Hu","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/acsomega.7b01483","article-title":"Insights into Key Interactions between Vancomycin and Bacterial Cell Wall Structures","volume":"3","author":"Wang","year":"2018","journal-title":"ACS Omega"},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S1074-5521(01)00075-8","article-title":"Direct interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis","volume":"8","author":"Yang","year":"2001","journal-title":"Chem. Biol."},{"key":"ref_366","unstructured":"World Health Organisation (2019). Selection and Use of Essential Medicines: Report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (Including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children), Report No.: 0512-3054."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","article-title":"Vancomycin-Resistant Enterococci","volume":"1","author":"Uttley","year":"1988","journal-title":"Lancet"},{"key":"ref_368","unstructured":"Clinical Laboratory Standards Institute (2021). Performance Standards for Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute. [31st ed.]. CLSI supplement M100."},{"key":"ref_369","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2022). Breakpoint Tables for Interpretation of MICs and Zone Diameters, The European Committee on Antimicrobial Susceptibility Testing. [12th ed.]."},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"10408","DOI":"10.1021\/bi00107a007","article-title":"Molecular Basis for Vancomycin Resistance in Enterococcus faecium BM4147: Biosynthesis of a Depsipeptide Peptidoglycan Precursor by Vancomycin Resistance Proteins VanH and VanA","volume":"30","author":"Bugg","year":"1991","journal-title":"Biochemistry"},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pro.3819","article-title":"Molecular mechanisms of vancomycin resistance","volume":"29","author":"Stogios","year":"2020","journal-title":"Protein Sci."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1042\/bj3041021","article-title":"Association constants for the binding of vancomycin and teicoplanin to N-acetyl-D-alanyl-D-alanine and N-acetyl-D-alanyl-D-serine","volume":"304","author":"Blanot","year":"1994","journal-title":"Biochem. J."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/AAC.45.2.375-381.2001","article-title":"Regulation of VanA- and VanB-Type Glycopeptide Resistance in Enterococci","volume":"45","author":"Arthur","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1021\/bi982843x","article-title":"Molecular Mechanism of VanHst, an \u03b1-Ketoacid Dehydrogenase Required for Glycopeptide Antibiotic Resistance from a Glycopeptide Producing Organism","volume":"38","author":"Marshall","year":"1999","journal-title":"Biochemistry"},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/jb.174.8.2582-2591.1992","article-title":"The VanS-VanR Two-Component Regulatory System Controls Synthesis of Depsipeptide Peptidoglycan Precursorsin Enterococcus faecium BM4147","volume":"174","author":"Arthur","year":"1992","journal-title":"J. Bacteriol."},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/bi00008a008","article-title":"Overexpression, purification, and characterization of VanX, a D-, D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147","volume":"34","author":"Wu","year":"1995","journal-title":"Biochemistry"},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1128\/AAC.38.9.1899","article-title":"Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors","volume":"38","author":"Arthur","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1365-2958.1998.01114.x","article-title":"Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci","volume":"30","author":"Arthur","year":"1998","journal-title":"Mol. Microbiol."},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1128\/AAC.36.7.1514","article-title":"Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147","volume":"36","author":"Wright","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1128\/AAC.00505-13","article-title":"Structural analysis of the role of Pseudomonas aeruginosa penicillin-binding protein 5 in \u03b2-lactam resistance","volume":"57","author":"Smith","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"e00819-16","DOI":"10.1128\/mBio.00819-16","article-title":"The Redundancy of Peptidoglycan Carboxypeptidases Ensures Robust Cell Shape Maintenance in Escherichia coli","volume":"7","author":"Peters","year":"2016","journal-title":"mBio"},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0378-1119(94)00851-I","article-title":"The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin","volume":"154","author":"Arthur","year":"1995","journal-title":"Gene"},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2958.1996.00617.x","article-title":"Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci","volume":"21","author":"Arthur","year":"1996","journal-title":"Mol. Microbiol."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1128\/AAC.00714-11","article-title":"D-Ala-D-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium","volume":"55","author":"Lebreton","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/AAC.01516-07","article-title":"Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel D-Ala-D-Ser Gene Cluster, vanL","volume":"52","author":"Boyd","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1099\/00221287-146-7-1727","article-title":"Serine and alanine racemase activities of VanT: A protein necessary for vancomycin resistance in Enterococcus gallinarum BM4174","volume":"146","author":"Arias","year":"2000","journal-title":"Microbiology"},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2958.1999.01294.x","article-title":"Characterization and modelling of VanT: A novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174","volume":"31","author":"Arias","year":"1999","journal-title":"Mol. Microbiol."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/AAC.44.6.1660-1666.2000","article-title":"vanC Cluster of Vancomycin-Resistant Enterococcus gallinarum BM4174","volume":"44","author":"Arias","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1128\/JB.184.23.6457-6464.2002","article-title":"vanE gene cluster of vancomycin-resistant Enterococcus faecalis BM4405","volume":"184","author":"Courvalin","year":"2002","journal-title":"J. Bacteriol."},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2958.2003.03737.x","article-title":"The vanG glycopeptide resistance operon from Enterococcus faecalis revisited","volume":"50","author":"Depardieu","year":"2003","journal-title":"Mol. Microbiol."},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jac\/dkg128","article-title":"Role of the transmembrane domain of the VanT serine racemase in resistance to vancomycin in Enterococcus gallinarum BM4174","volume":"51","author":"Arias","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_392","first-page":"e00806","article-title":"Structural and Functional Adaptation of Vancomycin Resistance VanT Serine Racemases","volume":"6","author":"Stogios","year":"2015","journal-title":"mBio"},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1107\/S1399004713024838","article-title":"Structural basis for the broad specificity of a new family of amino-acid racemases","volume":"70","author":"Espaillat","year":"2014","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_394","doi-asserted-by":"crossref","unstructured":"Wu, H.M., Kuan, Y.C., Chu, C.H., Hsu, W.H., and Wang, W.C. (2012). Crystal structures of lysine-preferred racemases, the non-antibiotic selectable markers for transgenic plants. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048301"},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1046\/j.1432-1033.2002.02946.x","article-title":"Purification and characterization of VanXYc, a D,D-dipeptidase\/D,D-carboxypeptidase in vancomycin-resistant Enterococcus gallinarum BM4174","volume":"269","author":"Podmore","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2958.1999.01604.x","article-title":"Gene vanXYc encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174","volume":"34","author":"Reynolds","year":"1999","journal-title":"Mol. Microbiol."},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/mdr.2017.0147","article-title":"Vancomycin-Resistant Enterococci: A Review of Antimicrobial Resistance Mechanisms and Perspectives of Human and Animal Health","volume":"24","author":"Ahmed","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13756-021-00967-y","article-title":"Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates","volume":"10","author":"Wu","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_399","doi-asserted-by":"crossref","unstructured":"Fong, I.W., Shlaes, D., and Drlica, K. (2018). Transmissible Antibiotic Resistance. Antimicrobial Resistance in the 21st Century, Springer International Publishing.","DOI":"10.1007\/978-3-319-78538-7"},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nrg1084","article-title":"Exploiting genomics, genetics and chemistry to combat antibiotic resistance","volume":"4","author":"Hughes","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"ref_401","unstructured":"Centers for Disease Control and Prevention (2022, August 12). Healthcare-associated Infections\u2014VRE and the Clinical Laboratory, Available online: https:\/\/www.cdc.gov\/hai\/settings\/lab\/vreclinical-laboratory.html."},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/AAC.39.7.1480","article-title":"Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum","volume":"39","author":"Sahm","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_403","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1042\/bj3010005","article-title":"Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174","volume":"301","author":"Reynolds","year":"1994","journal-title":"Biochem. J."},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/AAC.49.1.21-25.2005","article-title":"Vancomycin Resistance in Enterococci Due to Synthesis of Precursors Terminating in D-Alanyl-D-Serine","volume":"49","author":"Reynolds","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1099\/ijs.0.63891-0","article-title":"Reclassification of Enterococcus flavescens Pompei et al. 1992 as a later synonym of Enterococcus casseliflavus (ex Vaughan et al. 1979) Collins et al. 1984 and Enterococcus saccharominimus Vancanneyt et al. 2004 as a later synonym of Enterococcus italicus Fortina et al. 2004","volume":"56","author":"Naser","year":"2006","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1128\/AAC.46.10.3125-3132.2002","article-title":"Biochemical and Genetic Characterization of the vanC-2 Vancomycin Resistance Gene Cluster of Enterococcus casseliflavus ATCC 25788","volume":"46","author":"Dutta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/AAC.43.9.2161","article-title":"VanE, a New Type of Acquired Glycopeptide Resistance in Enterococcus faecalis BM4405","volume":"43","author":"Fines","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_408","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1128\/AAC.44.11.3224-3228.2000","article-title":"Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis","volume":"44","author":"McKessar","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/jac\/dkt270","article-title":"Fitness costs of various mobile genetic elements in Enterococcus faecium and Enterococcus faecalis","volume":"68","author":"Starikova","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_410","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1080\/22221751.2020.1769500","article-title":"The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: An epidemiological analysis of bloodstream infections","volume":"9","author":"Ayobami","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_411","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/IDR.S54125","article-title":"Vancomycin-resistant enterococcal infections: Epidemiology, clinical manifestations, and optimal management","volume":"8","author":"Crank","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"ref_412","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/jac\/dkab249","article-title":"Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks","volume":"76","author":"Tedim","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"16964","DOI":"10.1073\/pnas.1006855107","article-title":"Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci","volume":"107","author":"Foucault","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jcp.2004.024091","article-title":"Survivability of vancomycin resistant enterococci and fitness cost of vancomycin resistance acquisition","volume":"58","author":"Ramadhan","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.sjbs.2021.02.022","article-title":"Molecular determination of van genes among clinical isolates of enterococci at a hospital setting","volume":"28","author":"Suseela","year":"2021","journal-title":"Saudi. J. Biol. Sci."},{"key":"ref_416","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2047-2994-1-21","article-title":"Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU","volume":"1","author":"Werner","year":"2012","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_417","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.3389\/fmicb.2019.02568","article-title":"Novel Multidrug-Resistant Enterococcal Mobile Linear Plasmid pELF1 Encoding vanA and vanM Gene Clusters From a Japanese Vancomycin-Resistant Enterococci Isolate","volume":"10","author":"Hashimoto","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_418","doi-asserted-by":"crossref","unstructured":"Pouwels, K.B., Muller-Pebody, B., Smieszek, T., Hopkins, S., and Robotham, J.V. (2019). Selection and co-selection of antibiotic resistances among Escherichia coli by antibiotic use in primary care: An ecological analysis. PLoS ONE, 14.","DOI":"10.1101\/573360"},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/IDR.S55778","article-title":"Agriculture and food animals as a source of antimicrobial-resistant bacteria","volume":"8","author":"Economou","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13756-019-0623-2","article-title":"Selection and dissemination of antimicrobial resistance in Agri-food production","volume":"8","author":"Cheng","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_421","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1111\/jam.15492","article-title":"Heavy metal-induced selection and proliferation of antibiotic resistance: A review","volume":"132","author":"Vats","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/antibiotics4040567","article-title":"Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens","volume":"4","author":"Wales","year":"2015","journal-title":"Antibiotics"},{"key":"ref_423","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/1469-0691.12803","article-title":"Success stories of implementation of antimicrobial stewardship: A narrative review","volume":"20","author":"Huttner","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_424","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jgar.2020.09.014","article-title":"Successful antibiotic stewardship in hospitalised children in a developing nation","volume":"23","author":"Mustafa","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_425","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13756-020-00751-4","article-title":"The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: Results of a five-years pre-post analysis","volume":"9","author":"Alhumaid","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_426","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2017.07.017","article-title":"Antibiotic stewardship: Does it work in hospital practice? A review of the evidence base","volume":"23","author":"Hulscher","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_427","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fsoc.2020.00041","article-title":"Barriers and Facilitators to Implementation of Antibiotic Stewardship Programmes in Hospitals in Developed Countries: Insights From Transnational Studies","volume":"5","author":"Rzewuska","year":"2020","journal-title":"Front. Sociol."},{"key":"ref_428","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2147\/IDR.S354701","article-title":"Antibiotic Stewardship Related to Delayed Diagnosis and Poor Prognosis of Critically Ill Patients with Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Cohort Study","volume":"15","author":"Yang","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_429","doi-asserted-by":"crossref","unstructured":"Simm, R., Sletteme\u00e5s, J.S., Norstr\u00f6m, M., Dean, K.R., Kaldhusdal, M., and Urdahl, A.M. (2019). Significant reduction of vancomycin resistant E. faecium in the Norwegian broiler population coincided with measures taken by the broiler industry to reduce antimicrobial resistant bacteria. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0226101"},{"key":"ref_430","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jac\/dkh101","article-title":"A vancomycin-resistant Enterococcus faecium isolate from a Danish healthy volunteer, detected 7 years after the ban of avoparcin, is possibly related to pig isolates","volume":"53","author":"Hammerum","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_431","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1128\/AAC.05072-14","article-title":"Persistence of Vancomycin Resistance in Multiple Clones of Enterococcus faecium Isolated from Danish Broilers 15 Years after the Ban of Avoparcin","volume":"59","author":"Bortolaia","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_432","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1128\/AEM.70.10.5764-5768.2004","article-title":"Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use","volume":"70","author":"Manson","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_433","doi-asserted-by":"crossref","unstructured":"Wist, V., Morach, M., Schneeberger, M., Cernela, N., Stevens, M.J.A., Zurfluh, K., Stephan, R., and N\u00fcesch-Inderbinen, M. (2020). Phenotypic and Genotypic Traits of Vancomycin-Resistant Enterococci from Healthy Food-Producing Animals. Microorganisms, 8.","DOI":"10.3390\/microorganisms8020261"},{"key":"ref_434","first-page":"16959","article-title":"Vancomycin resistant enterococci in farm animals\u2014Occurrence and importance","volume":"2","author":"Nilsson","year":"2012","journal-title":"Infect. Ecol. Epidemiol."},{"key":"ref_435","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1462-2920.2006.01189.x","article-title":"Effect of banning vancomycin analogue avoparcin on vancomycin-resistant enterococci in chicken farms in Taiwan","volume":"9","author":"Lauderdale","year":"2007","journal-title":"Environ. Microbiol."},{"key":"ref_436","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1469-0691.2012.03829.x","article-title":"Enterococci of animal origin and their significance for public health","volume":"18","author":"Hammerum","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_437","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1089\/fpd.2010.0552","article-title":"Antimicrobial-resistant enterococci in animals and meat: A human health hazard?","volume":"7","author":"Hammerum","year":"2010","journal-title":"Foodborne Pathog. Dis."},{"key":"ref_438","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/107662902760326869","article-title":"Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice","volume":"8","author":"Johnsen","year":"2002","journal-title":"Microb. Drug Resist."},{"key":"ref_439","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1086\/313456","article-title":"An Outbreak of Vancomycin-Dependent Enterococcus faecium in a Bone Marrow Transplant Unit","volume":"29","author":"Kirkpatrick","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_440","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/AAC.43.1.41","article-title":"Vancomycin-Dependent Enterococcus faecalis Clinical Isolates and Revertant Mutants","volume":"43","author":"Chauvel","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_441","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-121-1-199407010-00004","article-title":"Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth","volume":"121","author":"Fraimow","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"ref_442","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9343(99)80270-8","article-title":"Vancomycin-resistant Enterococci","volume":"102","author":"Murray","year":"1997","journal-title":"Am. J. Med."},{"key":"ref_443","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3201\/eid1007.030993","article-title":"Nosocomial infection with vancomycin-dependent enterococci","volume":"10","author":"Tambyah","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_444","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1128\/jcm.33.10.2770-2773.1995","article-title":"Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy","volume":"33","author":"Dever","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"ref_445","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pathol.2018.11.012","article-title":"Vancomycin dependent Enterococcus: An unusual mutant?","volume":"51","author":"Sukumaran","year":"2019","journal-title":"Pathology"},{"key":"ref_446","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1590\/S0100-879X2011007500006","article-title":"Vancomycin-dependent Enterococcus faecium vanA: Characterization of the first case isolated in a university hospital in Brazil","volume":"44","author":"Kerbauy","year":"2011","journal-title":"Br. J. Med. Biol. Res."},{"key":"ref_447","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(97)80055-4","article-title":"Vancomycin-dependent Enterococcus","volume":"349","author":"Rossney","year":"1997","journal-title":"Lancet"},{"key":"ref_448","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00005373-200004000-00035","article-title":"Vancomycin-Dependent Enterococcal Strains: Case Report and Review","volume":"48","author":"Yowler","year":"2000","journal-title":"J. Trauma Acute Care Surg."},{"key":"ref_449","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.pathol.2020.08.030","article-title":"Vancomycin variable Enterococcus (VVE), E. faecium, harbouring the vanA gene complex","volume":"53","author":"Merlino","year":"2021","journal-title":"Pathology"},{"key":"ref_450","doi-asserted-by":"crossref","unstructured":"Abdullah, H.M., Marbjerg, L.H., Andersen, L., Hoegh, S.V., and Kemp, M. (2022). A Simple and Rapid Low-Cost Procedure for Detection of Vancomycin-Resistance Genes in Enterococci Reveals an Outbreak of Vancomycin-Variable Enterococcus faecium. Diagnostics, 12.","DOI":"10.3390\/diagnostics12092120"},{"key":"ref_451","doi-asserted-by":"crossref","unstructured":"Kohler, P., Eshaghi, A., Kim, H.C., Plevneshi, A., Green, K., Willey, B.M., McGeer, A., and Patel, S.N. (2018). Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193926"},{"key":"ref_452","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1128\/AAC.04490-14","article-title":"Vancomycin-variable enterococci can give rise to constitutive resistance during antibiotic therapy","volume":"59","author":"Thaker","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_453","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1093\/jac\/dkr379","article-title":"vanA-containing Enterococcus faecium susceptible to vancomycin and teicoplanin because of major nucleotide deletions in Tn1546","volume":"66","author":"Gagnon","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_454","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drup.2018.10.002","article-title":"Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature","volume":"40","author":"Bender","year":"2018","journal-title":"Drug Resist. Updates"},{"key":"ref_455","doi-asserted-by":"crossref","first-page":"1900503","DOI":"10.2807\/1560-7917.ES.2019.24.34.1900503","article-title":"Surveillance of vancomycin-resistant enterococci reveals shift in dominating clones and national spread of a vancomycin-variable vanA Enterococcus faecium ST1421-CT1134 clone, Denmark, 2015 to March 2019","volume":"24","author":"Hammerum","year":"2019","journal-title":"Eurosurveillance"},{"key":"ref_456","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"ref_457","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jgar.2014.04.006","article-title":"Vancomycin-intermediate resistance in Staphylococcus aureus","volume":"2","author":"Hiramatsu","year":"2014","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_458","unstructured":"Centers for Disease Control and Prevention (2002). Staphylococcus aureus Resistant to Vancomycin\u2014United States, 2002. MMWR Morb. Mortal. Wkly Rep., 51, 565\u2013567."},{"key":"ref_459","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/AAC.47.10.3040-3045.2003","article-title":"Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods","volume":"47","author":"Liu","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_460","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cmi.2017.03.027","article-title":"Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors","volume":"23","author":"Cameron","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_461","doi-asserted-by":"crossref","first-page":"596942","DOI":"10.3389\/fmicb.2020.596942","article-title":"Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive Staphylococcus aureus Strains","volume":"11","author":"Jin","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_462","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/iai.65.9.3606-3614.1997","article-title":"Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion","volume":"65","author":"Ohlsen","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_463","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4103\/ijmm.IJMM_17_311","article-title":"Survivability and Fitness Cost of Heterogeneous Vancomycin-intermediate Staphylococcus aureus","volume":"35","author":"Singh","year":"2017","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_464","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1128\/AAC.02470-13","article-title":"\u201cSlow VISA,\u201d a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3","volume":"58","author":"Saito","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_465","doi-asserted-by":"crossref","first-page":"e00452-17","DOI":"10.1128\/AAC.00452-17","article-title":"Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus","volume":"61","author":"Katayama","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_466","doi-asserted-by":"crossref","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: A systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_467","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_468","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1128\/AAC.01702-08","article-title":"Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus","volume":"53","author":"Foucault","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_469","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/AAC.00420-16","article-title":"Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus","volume":"60","author":"Katayama","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_470","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: Resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_471","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/mdr.2015.0330","article-title":"First Report on Vancomycin-Resistant Staphylococcus aureus in Bovine and Caprine Milk","volume":"22","author":"Bhattacharyya","year":"2016","journal-title":"Microb. Drug Resist."},{"key":"ref_472","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fmicb.2013.00316","article-title":"Reduced vancomycin susceptibility in porcine ST9 MRSA isolates","volume":"4","author":"Kwok","year":"2013","journal-title":"Front. Microbiol."},{"key":"ref_473","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1590\/0074-02760160276","article-title":"Vancomycin-intermediate livestock-associated methicillin-resistant Staphylococcus aureus ST398\/t9538 from swine in Brazil","volume":"111","author":"Moreno","year":"2016","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_474","doi-asserted-by":"crossref","unstructured":"Silva, V., Monteiro, A., Pereira, J.E., Maltez, L., Igrejas, G., and Poeta, P. (2022). MRSA in Humans, Pets and Livestock in Portugal: Where We Came from and Where We Are Going. Pathogens, 11.","DOI":"10.3390\/pathogens11101110"},{"key":"ref_475","doi-asserted-by":"crossref","first-page":"e00182-20","DOI":"10.1128\/CMR.00182-20","article-title":"Staphylococcus aureus in Agriculture: Lessons in Evolution from a Multispecies Pathogen","volume":"34","author":"Park","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_476","doi-asserted-by":"crossref","first-page":"e13202","DOI":"10.1111\/mcn.13202","article-title":"Leveraging water, sanitation and hygiene for nutrition in low- and middle-income countries: A conceptual framework","volume":"17","author":"Zavala","year":"2021","journal-title":"Matern. Child Nutr."},{"key":"ref_477","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2019.06.002","article-title":"Hand hygiene in low- and middle-income countries","volume":"86","author":"Loftus","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_478","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1016\/j.ijid.2009.07.023","article-title":"Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid","volume":"14","author":"Balkhair","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"ref_479","doi-asserted-by":"crossref","first-page":"196","DOI":"10.11604\/pamj.2016.25.196.9476","article-title":"Proper use of antibiotics: Situation of linezolid at the intensive care unit of the Tunisian Military Hospital","volume":"25","author":"Safa","year":"2016","journal-title":"Pan Afr. Med. J."},{"key":"ref_480","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/dkv420","article-title":"Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M)","volume":"71","author":"Fiedler","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_481","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.2147\/IDR.S208298","article-title":"Vancomycin-resistant enterococcal infection in a Thai university hospital: Clinical characteristics, treatment outcomes, and synergistic effect","volume":"12","author":"Hemapanpairoa","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_482","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/00365540500434687","article-title":"Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia","volume":"38","author":"Kvirikadze","year":"2006","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_483","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jinf.2006.11.007","article-title":"Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients","volume":"54","author":"Poutsiaka","year":"2007","journal-title":"J. Infect."},{"key":"ref_484","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkx349","article-title":"Daptomycin","volume":"73","author":"Heidary","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_485","doi-asserted-by":"crossref","unstructured":"Ba\u00ebtz, B., Boudrioua, A., Hartke, A., and Giraud, C. (2021). Alternatives to Fight Vancomycin-Resistant Staphylococci and Enterococci. Antibiotics, 10.","DOI":"10.3390\/antibiotics10091116"},{"key":"ref_486","doi-asserted-by":"crossref","first-page":"e00181-19","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial Resistance in ESKAPE Pathogens","volume":"33","author":"Forde","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_487","doi-asserted-by":"crossref","unstructured":"Terreni, M., Taccani, M., and Pregnolato, M. (2021). New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives. Molecules, 26.","DOI":"10.3390\/molecules26092671"},{"key":"ref_488","unstructured":"World Health Organisation (2021). 2020 Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis."},{"key":"ref_489","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/QCO.0000000000000800","article-title":"New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections","volume":"35","author":"Hindy","year":"2022","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_490","doi-asserted-by":"crossref","unstructured":"Waglechner, N., and Wright, G.D. (2017). Antibiotic resistance: It\u2019s bad, but why isn\u2019t it worse?. BMC Biol., 15.","DOI":"10.1186\/s12915-017-0423-1"},{"key":"ref_491","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41231-019-0050-7","article-title":"Lost in translation: The valley of death across preclinical and clinical divide\u2014Identification of problems and overcoming obstacles","volume":"4","author":"Seyhan","year":"2019","journal-title":"Transl. Med. Commun."},{"key":"ref_492","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/d41586-020-02418-x","article-title":"The antibiotic paradox: Why companies can\u2019t afford to create life-saving drugs","volume":"584","author":"McKenna","year":"2020","journal-title":"Nature"},{"key":"ref_493","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.embor.7400236","article-title":"Accelerating drug discovery","volume":"5","author":"Kraljevic","year":"2004","journal-title":"EMBO Rep."},{"key":"ref_494","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1038\/s41467-021-26244-5","article-title":"Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus","volume":"12","author":"Payne","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_495","doi-asserted-by":"crossref","unstructured":"M\u00fchlberg, E., Umst\u00e4tter, F., Domhan, C., Hertlein, T., Ohlsen, K., Krause, A., Kleist, C., Beijer, B., Zimmermann, S., and Haberkorn, U. (2020). Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci. Pharmaceuticals, 13.","DOI":"10.3390\/ph13060110"},{"key":"ref_496","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody\u2013antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"key":"ref_497","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molmed.2016.12.008","article-title":"Antibody-Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections","volume":"23","author":"Mariathasan","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_498","doi-asserted-by":"crossref","first-page":"835677","DOI":"10.3389\/fmicb.2022.835677","article-title":"The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections","volume":"13","author":"Cavaco","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_499","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1021\/acs.biomac.1c00082","article-title":"Antibody-Conjugated Nanocarriers for Targeted Antibiotic Delivery: Application in the Treatment of Bacterial Biofilms","volume":"22","author":"Le","year":"2021","journal-title":"Biomacromolecules"},{"key":"ref_500","doi-asserted-by":"crossref","unstructured":"Zhou, C., Cai, H., Baruch, A., Lewin-Koh, N., Yang, M., Guo, F., Xu, D., Deng, R., Hazenbos, W., and Kamath, A.V. (2019). Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imaging. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224096"},{"key":"ref_501","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1080\/19420862.2019.1627152","article-title":"Preclinical and translational pharmacokinetics of a novel THIOMAB\u2122 antibody-antibiotic conjugate against Staphylococcus aureus","volume":"11","author":"Deng","year":"2019","journal-title":"MAbs"},{"key":"ref_502","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/dmd.120.000092","article-title":"Characterization of Tissue Distribution, Catabolism, and Elimination of an Anti\u2013Staphylococcus aureus THIOMAB Antibody-Antibiotic Conjugate in Rats","volume":"48","author":"Cai","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"ref_503","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/ofid\/ofaa439.477","article-title":"A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multiple-ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients with Staphylococcus aureus Bacteremia Receiving Standard-of-care Antibiotics","volume":"7","author":"Lim","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_504","doi-asserted-by":"crossref","first-page":"S666","DOI":"10.1093\/ofid\/ofaa439.1488","article-title":"Comparison of Pharmacokinetics of DSTA4637S, a novel THIOMABTM Antibody-Antibiotic Conjugate, in Patients with Staphylococcus aureus Bacteremia Receiving Standard-of-Care Antibiotics with Pharmacokinetics in Healthy Volunteers","volume":"7","author":"Rymut","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_505","doi-asserted-by":"crossref","first-page":"119647","DOI":"10.1016\/j.lfs.2021.119647","article-title":"Synthetic antimicrobial peptides: Characteristics, design, and potential as alternative molecules to overcome microbial resistance","volume":"278","author":"Lima","year":"2021","journal-title":"Life Sci."},{"key":"ref_506","doi-asserted-by":"crossref","first-page":"e00469-17","DOI":"10.1128\/AAC.00469-17","article-title":"Antimicrobial Activity and Cell Selectivity of Synthetic and Biosynthetic Cationic Polymers","volume":"61","author":"Venkatesh","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_507","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bsheal.2022.03.009","article-title":"Antimicrobial peptide-inspired antibacterial polymeric materials for biosafety","volume":"4","author":"Lin","year":"2022","journal-title":"Biosaf. Health"},{"key":"ref_508","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0022034516679973","article-title":"Antimicrobial Peptides: Mechanisms of Action and Resistance","volume":"96","author":"Bechinger","year":"2017","journal-title":"J. Dent. Res."},{"key":"ref_509","doi-asserted-by":"crossref","unstructured":"Kamaruzzaman, N.F., Tan, L.P., Hamdan, R.H., Choong, S.S., Wong, W.K., Gibson, A.J., Chivu, A., and Pina, M.F. (2019). Antimicrobial Polymers: The Potential Replacement of Existing Antibiotics?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112747"},{"key":"ref_510","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fbioe.2020.00910","article-title":"The Mechanisms and the Applications of Antibacterial Polymers in Surface Modification on Medical Devices","volume":"8","author":"Qiu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_511","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/acsinfecdis.0c00016","article-title":"Combined Efficacy of an Antimicrobial Cationic Peptide Polymer with Conventional Antibiotics to Combat Multidrug-Resistant Pathogens","volume":"6","author":"Thappeta","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_512","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"key":"ref_513","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13287-020-01807-3","article-title":"Antimicrobial activity of mesenchymal stem cells against Staphylococcus aureus","volume":"11","author":"Yagi","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_514","doi-asserted-by":"crossref","first-page":"180.111","DOI":"10.4049\/jimmunol.190.Supp.180.11","article-title":"Activated mesenchymal stem cells amplify antibiotic activity against chronic Staphylococcus aureus infection (P5056)","volume":"190","author":"Johnson","year":"2013","journal-title":"J. Immunol."},{"key":"ref_515","doi-asserted-by":"crossref","first-page":"819921","DOI":"10.3389\/fvets.2022.819921","article-title":"The Antimicrobial Peptide MPX Can Kill Staphylococcus aureus, Reduce Biofilm Formation, and Effectively Treat Bacterial Skin Infections in Mice","volume":"9","author":"Zhu","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"ref_516","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Aristiz\u00e1bal, I., and Ocampo-Ib\u00e1\u00f1ez, I.D. (2021). Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant Staphylococcus aureus Strains: Classification, Structures, and Mechanisms of Action. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157927"},{"key":"ref_517","doi-asserted-by":"crossref","unstructured":"Eckhard, L.H., Sol, A., Abtew, E., Shai, Y., Domb, A.J., Bachrach, G., and Beyth, N. (2014). Biohybrid Polymer-Antimicrobial Peptide Medium against Enterococcus faecalis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109413"},{"key":"ref_518","doi-asserted-by":"crossref","unstructured":"Mergoni, G., Manfredi, M., Bertani, P., Ciociola, T., Conti, S., and Giovati, L. (2021). Activity of Two Antimicrobial Peptides against Enterococcus faecalis in a Model of Biofilm-Mediated Endodontic Infection. Antibiotics, 10.","DOI":"10.3390\/antibiotics10101220"},{"key":"ref_519","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fchem.2017.00051","article-title":"Buwchitin: A Ruminal Peptide with Antimicrobial Potential against Enterococcus faecalis","volume":"5","author":"Oyama","year":"2017","journal-title":"Front. Chem."},{"key":"ref_520","doi-asserted-by":"crossref","unstructured":"Wu, C.L., Hsueh, J.Y., Yip, B.S., Chih, Y.H., Peng, K.L., and Cheng, J.W. (2020). Antimicrobial Peptides Display Strong Synergy with Vancomycin Against Vancomycin-Resistant E. faecium, S. aureus, and Wild-Type E. coli. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134578"},{"key":"ref_521","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbamem.2017.01.037","article-title":"LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity","volume":"1859","author":"Rajasekaran","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_522","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41598-017-01698-0","article-title":"A short artificial antimicrobial peptide shows potential to prevent or treat bone infections","volume":"7","author":"Bormann","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_523","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijantimicag.2018.04.019","article-title":"Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37","volume":"52","author":"Lin","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_524","doi-asserted-by":"crossref","first-page":"eaan4044","DOI":"10.1126\/scitranslmed.aan4044","article-title":"The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms","volume":"10","author":"Riool","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_525","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/IDR.S166236","article-title":"Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides","volume":"11","author":"Almaaytah","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_526","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/med.21879","article-title":"Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections","volume":"42","author":"Zhu","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_527","first-page":"263","article-title":"Custom-design of intrinsically antimicrobial polyurethane hydrogels as multifunctional injectable delivery systems for mini-invasive wound treatment","volume":"2","author":"Laurano","year":"2021","journal-title":"Eng. Regen."},{"key":"ref_528","doi-asserted-by":"crossref","unstructured":"Dardeer, H.M., Toghan, A., Zaki, M.E.A., and Elamary, R.B. (2022). Design, Synthesis and Evaluation of Novel Antimicrobial Polymers Based on the Inclusion of Polyethylene Glycol\/TiO2 Nanocomposites in Cyclodextrin as Drug Carriers for Sulfaguanidine. Polymers, 14.","DOI":"10.3390\/polym14020227"},{"key":"ref_529","doi-asserted-by":"crossref","first-page":"16162","DOI":"10.1038\/nmicrobiol.2016.162","article-title":"Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers","volume":"1","author":"Lam","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_530","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/07388551.2020.1828810","article-title":"Strategies for antimicrobial peptide coatings on medical devices: A review and regulatory science perspective","volume":"41","author":"Cheng","year":"2021","journal-title":"Crit. Rev. Biotechnol."},{"key":"ref_531","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/acsinfecdis.9b00049","article-title":"Synergy between Synthetic Antimicrobial Polymer and Antibiotics: A Promising Platform To Combat Multidrug-Resistant Bacteria","volume":"5","author":"Sadrearhami","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_532","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/s41467-021-26221-y","article-title":"Addressing MRSA infection and antibacterial resistance with peptoid polymers","volume":"12","author":"Xie","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_533","doi-asserted-by":"crossref","first-page":"e00502-17","DOI":"10.1128\/AAC.00502-17","article-title":"NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus","volume":"61","author":"Mercer","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_534","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1021\/bm500557d","article-title":"Cationic Methacrylate Polymers as Topical Antimicrobial Agents against Staphylococcus aureus Nasal Colonization","volume":"15","author":"Thoma","year":"2014","journal-title":"Biomacromolecules"},{"key":"ref_535","doi-asserted-by":"crossref","first-page":"641646","DOI":"10.3389\/fmed.2021.641646","article-title":"Broad-Spectrum Photo-Antimicrobial Polymers Based on Cationic Polystyrene and Rose Bengal","volume":"8","author":"Gavara","year":"2021","journal-title":"Front. Med."},{"key":"ref_536","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection","volume":"5","author":"Lin","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_537","doi-asserted-by":"crossref","unstructured":"Lehman, S.M., Mearns, G., Rankin, D., Cole, R.A., Smrekar, F., Branston, S.D., and Morales, S. (2019). Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant Staphylococcus aureus Infections. Viruses, 11.","DOI":"10.3390\/v11010088"},{"key":"ref_538","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamaoto.2019.1191","article-title":"Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus","volume":"145","author":"Ooi","year":"2019","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_539","doi-asserted-by":"crossref","first-page":"e2008007118","DOI":"10.1073\/pnas.2008007118","article-title":"Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections","volume":"118","author":"Berryhill","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_540","doi-asserted-by":"crossref","first-page":"602902","DOI":"10.3389\/fmicb.2021.602902","article-title":"JD419, a Staphylococcus aureus Phage With a Unique Morphology and Broad Host Range","volume":"12","author":"Feng","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_541","doi-asserted-by":"crossref","first-page":"e023080","DOI":"10.1161\/JAHA.121.023080","article-title":"Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin Act Synergistically Against Staphylococcus aureus Experimental Infective Endocarditis","volume":"11","author":"Save","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_542","doi-asserted-by":"crossref","first-page":"907314","DOI":"10.3389\/fcimb.2022.907314","article-title":"Bacteriophage Therapy for Staphylococcus aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials","volume":"12","author":"Plumet","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_543","doi-asserted-by":"crossref","unstructured":"El Haddad, L., Angelidakis, G., Clark, J.R., Mendoza, J.F., Terwilliger, A.L., Chaftari, C.P., Duna, M., Yusuf, S.T., Harb, C.P., and Stibich, M. (2022). Genomic and Functional Characterization of Vancomycin-Resistant Enterococci-Specific Bacteriophages in the Galleria mellonella Wax Moth Larvae Model. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081591"},{"key":"ref_544","doi-asserted-by":"crossref","first-page":"e01304-16","DOI":"10.1128\/mBio.01304-16","article-title":"Molecular Basis for Lytic Bacteriophage Resistance in Enterococci","volume":"7","author":"Duerkop","year":"2016","journal-title":"mBio"},{"key":"ref_545","doi-asserted-by":"crossref","first-page":"e00085-19","DOI":"10.1128\/IAI.00085-19","article-title":"Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci","volume":"87","author":"Chatterjee","year":"2019","journal-title":"Infect. Immun."},{"key":"ref_546","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1038\/s41598-019-43115-8","article-title":"Efficacy and safety assessment of two enterococci phages in an in vitro biofilm wound model","volume":"9","author":"Melo","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_547","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.3389\/fmicb.2019.02877","article-title":"The Novel Enterococcus Phage vB_EfaS_HEf13 Has Broad Lytic Activity Against Clinical Isolates of Enterococcus faecalis","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_548","doi-asserted-by":"crossref","first-page":"866382","DOI":"10.3389\/fmicb.2022.866382","article-title":"Enterococcus faecalis Bacteriophage vB_EfaS_efap05-1 Targets the Surface Polysaccharide and ComEA Protein as the Receptors","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_549","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fmicb.2017.00837","article-title":"The Bacteriophage EF-P29 Efficiently Protects against Lethal Vancomycin-Resistant Enterococcus faecalis and Alleviates Gut Microbiota Imbalance in a Murine Bacteremia Model","volume":"8","author":"Cheng","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_550","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mib.2020.06.003","article-title":"Molecular mechanisms of enterococcal-bacteriophage interactions and implications for human health","volume":"56","author":"Canfield","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_551","doi-asserted-by":"crossref","unstructured":"Tkachev, P.V., Pchelin, I.M., Azarov, D.V., Gorshkov, A.N., Shamova, O.V., Dmitriev, A.V., and Goncharov, A.E. (2022). Two Novel Lytic Bacteriophages Infecting Enterococcus spp. Are Promising Candidates for Targeted Antibacterial Therapy. Viruses, 14.","DOI":"10.3390\/v14040831"},{"key":"ref_552","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AEM.00096-15","article-title":"Targeting Enterococcus faecalis Biofilms with Phage Therapy","volume":"81","author":"Khalifa","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_553","doi-asserted-by":"crossref","first-page":"698807","DOI":"10.3389\/fcimb.2021.698807","article-title":"Characterization of an Enterococcus faecalis Bacteriophage vB_EfaM_LG1 and Its Synergistic Effect With Antibiotic","volume":"11","author":"Song","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_554","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/17453674.2021.1968714","article-title":"Bacteriophage therapy cures a recurrent Enterococcus faecalis infected total hip arthroplasty? A case report","volume":"92","author":"Neuts","year":"2021","journal-title":"Acta Orthop."},{"key":"ref_555","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12223-009-0064-z","article-title":"Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis\u2014Case report","volume":"54","author":"Letkiewicz","year":"2009","journal-title":"Folia Microbiol."},{"key":"ref_556","doi-asserted-by":"crossref","unstructured":"Paul, K., Merabishvili, M., Hazan, R., Christner, M., Herden, U., Gelman, D., Khalifa, L., Yerushalmy, O., Coppenhagen-Glazer, S., and Harbauer, T. (2021). Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation. Viruses, 13.","DOI":"10.3390\/v13091785"},{"key":"ref_557","doi-asserted-by":"crossref","first-page":"eaat0882","DOI":"10.1126\/scitranslmed.aat0882","article-title":"Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus","volume":"11","author":"Chan","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_558","doi-asserted-by":"crossref","first-page":"e26664","DOI":"10.7554\/eLife.26664","article-title":"Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations","volume":"6","author":"Hullahalli","year":"2017","journal-title":"Elife"},{"key":"ref_559","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: A review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_560","doi-asserted-by":"crossref","first-page":"e00227-10","DOI":"10.1128\/mBio.00227-10","article-title":"Multidrug-Resistant Enterococci Lack CRISPR-cas","volume":"1","author":"Palmer","year":"2010","journal-title":"mBio"},{"key":"ref_561","doi-asserted-by":"crossref","first-page":"e00414-18","DOI":"10.1128\/mBio.00414-18","article-title":"An Attenuated CRISPR-Cas System in Enterococcus faecalis Permits DNA Acquisition","volume":"9","author":"Hullahalli","year":"2018","journal-title":"mBio"},{"key":"ref_562","doi-asserted-by":"crossref","first-page":"e00464-19","DOI":"10.1128\/mSphere.00464-19","article-title":"Enterococcus faecalis CRISPR-Cas Is a Robust Barrier to Conjugative Antibiotic Resistance Dissemination in the Murine Intestine","volume":"4","author":"Price","year":"2019","journal-title":"mSphere"},{"key":"ref_563","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/crispr.2021.0046","article-title":"Functional Characterization of Type III-A CRISPR-Cas in a Clinical Human Methicillin-R Staphylococcus aureus Strain","volume":"4","author":"Li","year":"2021","journal-title":"CRISPR J."},{"key":"ref_564","doi-asserted-by":"crossref","first-page":"207","DOI":"10.29074\/ascls.30.4.207","article-title":"Suppression of Antimicrobial Resistance in MRSA Using CRISPR-dCas9","volume":"30","author":"Wang","year":"2017","journal-title":"Clin. Lab. Sci."},{"key":"ref_565","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/abbs\/gmx074","article-title":"CRISPR\/Cas9-based efficient genome editing in Staphylococcus aureus","volume":"49","author":"Liu","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_566","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12951-021-01132-8","article-title":"Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections","volume":"19","author":"Wu","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_567","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1021\/jacs.6b13317","article-title":"Rapid and Efficient Genome Editing in Staphylococcus aureus by Using an Engineered CRISPR\/Cas9 System","volume":"139","author":"Chen","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"ref_568","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4939-9849-4_9","article-title":"Genetic Manipulation of MRSA Using CRISPR\/Cas9 Technology","volume":"2069","author":"Chen","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_569","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41467-020-16731-6","article-title":"Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria","volume":"11","author":"Kiga","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_570","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nbt.3043","article-title":"Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials","volume":"32","author":"Bikard","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_571","doi-asserted-by":"crossref","first-page":"742040","DOI":"10.3389\/fmicb.2021.742040","article-title":"Combining CRISPR-Cas12a-Based Technology and Metagenomics Next Generation Sequencing: A New Paradigm for Rapid and Full-Scale Detection of Microbes in Infectious Diabetic Foot Samples","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_572","doi-asserted-by":"crossref","first-page":"841905","DOI":"10.3389\/fmicb.2022.841905","article-title":"Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic Resistance","volume":"13","author":"Schuch","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_573","unstructured":"ContraFect (2022, August 29). Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase (DISRUPT) ClinicalTrials.gov: National Institutes of Health, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04160468."},{"key":"ref_574","doi-asserted-by":"crossref","first-page":"e0311720","DOI":"10.1128\/JCM.03117-20","article-title":"Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity","volume":"59","author":"Traczewski","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_575","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3389\/fimmu.2018.02252","article-title":"Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials","volume":"9","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_576","doi-asserted-by":"crossref","first-page":"e02009-18","DOI":"10.1128\/AAC.02009-18","article-title":"Efficacy of Intranasal Administration of the Recombinant Endolysin SAL200 in a Lethal Murine Staphylococcus aureus Pneumonia Model","volume":"63","author":"Bae","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_577","unstructured":"Kim, H.-B., and Park, W.B. (2022, November 23). Phase IIa Clinical Study of N-Rephasin\u00ae SAL200, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT03089697."},{"key":"ref_578","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.02526-12","article-title":"Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus","volume":"57","author":"Gilmer","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_579","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/fmb-2017-0235","article-title":"Phage-derived lysins as therapeutic agents against multidrug-resistant Enterococcus faecalis","volume":"13","author":"Gu","year":"2018","journal-title":"Future Microbiol."},{"key":"ref_580","doi-asserted-by":"crossref","first-page":"574739","DOI":"10.3389\/fmicb.2020.574739","article-title":"Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci","volume":"11","author":"Dam","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_581","unstructured":"ContraFect (2022, November 24). Product Pipeline: Developing Drugs for Drug-Resistant, Life Threatening Infections. Available online: https:\/\/www.contrafect.com\/pipeline\/overview."},{"key":"ref_582","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","article-title":"Fecal microbiota transplantation: Review and update","volume":"118","author":"Wang","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_583","doi-asserted-by":"crossref","unstructured":"Wei, Y., Gong, J., Zhu, W., Guo, D., Gu, L., Li, N., and Li, J. (2015). Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-0973-1"},{"key":"ref_584","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fcimb.2019.00006","article-title":"Two Strains of Lactobacilli Effectively Decrease the Colonization of VRE in a Mouse Model","volume":"9","author":"Li","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_585","doi-asserted-by":"crossref","first-page":"ofv078","DOI":"10.1093\/ofid\/ofv078","article-title":"Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant","volume":"2","author":"Stripling","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"ref_586","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.medmal.2018.11.002","article-title":"Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak","volume":"49","author":"Davido","year":"2019","journal-title":"Med. Mal. Infect."},{"key":"ref_587","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/s41598-018-20617-5","article-title":"The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus","volume":"8","author":"Yeo","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_588","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature26157","article-title":"A new class of synthetic retinoid antibiotics effective against bacterial persisters","volume":"556","author":"Kim","year":"2018","journal-title":"Nature"},{"key":"ref_589","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.2174\/1381612821666150506154434","article-title":"Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections","volume":"21","author":"Younis","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_590","doi-asserted-by":"crossref","first-page":"579806","DOI":"10.3389\/fmicb.2021.579806","article-title":"Drug Repurposing: In vitro and in vivo Antimicrobial and Antibiofilm Effects of Bithionol Against Enterococcus faecalis and Enterococcus faecium","volume":"12","author":"She","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_591","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1038\/s41598-018-26674-0","article-title":"Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci","volume":"8","author":"AbdelKhalek","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_592","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s11224-022-02020-z","article-title":"Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2","volume":"33","author":"Niranjan","year":"2022","journal-title":"Struct. Chem."},{"key":"ref_593","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_594","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1002\/jcb.26677","article-title":"Autophagy inhibition promotes phagocytosis of macrophage and protects mice from methicillin-resistant Staphylococcus aureus pneumonia","volume":"119","author":"Zhu","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_595","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcrc.2018.11.003","article-title":"Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study","volume":"49","author":"Hawchar","year":"2019","journal-title":"J. Crit. Care"},{"key":"ref_596","doi-asserted-by":"crossref","first-page":"718191","DOI":"10.3389\/fimmu.2021.718191","article-title":"Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis\u2013 A Phase Ib Clinical Trial","volume":"12","author":"Abutbul","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_597","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1021\/acsinfecdis.0c00774","article-title":"Lipid-Polymer Hybrid Nanoparticles Enhance the Potency of Ampicillin against Enterococcus faecalis in a Protozoa Infection Model","volume":"7","author":"Tan","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_598","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1039\/D0TB02704A","article-title":"Ca\u2013Si mesoporous nanoparticles with the optimal Ag\u2013Zn ratio inhibit the Enterococcus faecalis infection of teeth through dentinal tubule infiltration: An in vitro and in vivo study","volume":"9","author":"Sun","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_599","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1038\/s41467-021-23659-y","article-title":"Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_600","doi-asserted-by":"crossref","first-page":"33608","DOI":"10.1039\/D0RA06120D","article-title":"Treatment of Staphylococcus aureus skin infection in vivo using rifampicin loaded lipid nanoparticles","volume":"10","author":"Walduck","year":"2020","journal-title":"Rsc. Adv."},{"key":"ref_601","doi-asserted-by":"crossref","first-page":"e02391-18","DOI":"10.1128\/mBio.02391-18","article-title":"Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance","volume":"9","author":"Bohlmann","year":"2018","journal-title":"mBio"},{"key":"ref_602","doi-asserted-by":"crossref","first-page":"eabb3791","DOI":"10.1126\/scitranslmed.abb3791","article-title":"Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis","volume":"12","author":"Bohlmann","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_603","doi-asserted-by":"crossref","unstructured":"De Oliveira, D.M.P., Keller, B., Hayes, A.J., Ong, C.Y., Harbison-Price, N., El-Deeb, I.M., Li, G., Keller, N., Bohlmann, L., and Brouwer, S. (2022). Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria. Antibiotics, 11.","DOI":"10.3390\/antibiotics11040449"},{"key":"ref_604","doi-asserted-by":"crossref","first-page":"e03517-21","DOI":"10.1128\/mbio.03517-21","article-title":"Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection","volume":"13","author":"Oliveira","year":"2022","journal-title":"mBio"},{"key":"ref_605","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phymed.2010.09.003","article-title":"Reversing \u03b2-lactam antibiotic resistance of Staphylococcus aureus with galangin from Alpinia officinarum Hance and synergism with ceftazidime","volume":"18","author":"Eumkeb","year":"2010","journal-title":"Phytomedicine"},{"key":"ref_606","doi-asserted-by":"crossref","first-page":"610070","DOI":"10.3389\/fmicb.2020.610070","article-title":"Novel Opportunity to Reverse Antibiotic Resistance: To Explore Traditional Chinese Medicine With Potential Activity Against Antibiotics-Resistance Bacteria","volume":"11","author":"Su","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_607","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s42003-021-02854-z","article-title":"Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine","volume":"4","author":"Liu","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_608","doi-asserted-by":"crossref","first-page":"113334","DOI":"10.1016\/j.biopha.2022.113334","article-title":"Identification of an anti-virulence drug that reverses antibiotic resistance in multidrug resistant bacteria","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_609","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1128\/IAI.00230-12","article-title":"Protein A-Specific Monoclonal Antibodies and Prevention of Staphylococcus aureus Disease in Mice","volume":"80","author":"Kim","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_610","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.20092514","article-title":"Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice","volume":"207","author":"Kim","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_611","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/infdis\/jiy597","article-title":"Staphylococcus aureus Decolonization of Mice With Monoclonal Antibody Neutralizing Protein A","volume":"219","author":"Chen","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_612","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/ofid\/ofw172.1057","article-title":"Safety and Tolerability of 514G3, a True Human Anti-Protein A Monoclonal Antibody for the Treatment of S. aureus Bacteremia","volume":"3","author":"Huynh","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_613","unstructured":"Rupp, M. (2022, November 28). A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized with Bacteremia Due to Staphylococcus Aureus, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02357966."},{"key":"ref_614","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1016\/j.vaccine.2021.05.072","article-title":"A protein A based Staphylococcus aureus vaccine with improved safety","volume":"39","author":"Shi","year":"2021","journal-title":"Vaccine"},{"key":"ref_615","doi-asserted-by":"crossref","first-page":"705360","DOI":"10.3389\/fimmu.2021.705360","article-title":"Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies","volume":"12","author":"Clegg","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_616","unstructured":"World Health Organization (2022). Bacterial Vaccines in Clinical and Preclinical Development 2021: An Overview and Analysis."},{"key":"ref_617","doi-asserted-by":"crossref","first-page":"704247","DOI":"10.3389\/fmicb.2021.704247","article-title":"Staphylococcus aureus Putative Vaccines Based on the Virulence Factors: A Mini-Review","volume":"12","author":"Mirzaei","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_618","doi-asserted-by":"crossref","unstructured":"Kalfopoulou, E., and Huebner, J. (2020). Advances and Prospects in Vaccine Development against Enterococci. Cells, 9.","DOI":"10.3390\/cells9112397"},{"key":"ref_619","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13099-022-00495-z","article-title":"Designing a novel multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Enterococcus faecium bacterium","volume":"14","author":"Dey","year":"2022","journal-title":"Gut. Pathog."},{"key":"ref_620","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/infdis\/jiz357","article-title":"Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage","volume":"220","author":"Laverde","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_621","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1074\/jbc.M115.655852","article-title":"A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium","volume":"290","author":"Kodali","year":"2015","journal-title":"J. Biol. Chem."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/1\/24\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:47:01Z","timestamp":1760147221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/1\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":621,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["microorganisms11010024"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11010024","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]}}}